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Vibrio species are indigenous to the marine environment, and the genus includes 12 human 
pathogenic species which has shown a strong seasonality and are most abundant when the sea 
temperature exceeds 18 °C. The last two decades, an increased number of infections have 
been reported in areas where this previously have been rare, and this has been linked to 
increased temperatures due to global warming. Furthermore, the World Health Organization 
(WHO) has ranked antimicrobial resistance as one of the biggest threats to global health, food 
security and development. This is the first larger study on the occurrence of potentially 
pathogenic Vibrio spp. in the Norwegian marine environment since 2006, and to my 
knowledge the first on Norwegian pelagic fish. 
A number of 20 water samples, 60 fish and 16 bivalve molluscs were examined for the 
presence of Vibrio spp., and isolated bacteria were characterised morphologically, 
biochemically and by molecular methods. Antimicrobial susceptibility testing was conducted 
by a disk diffusion method. Isolates belonging to V. anguillarum were additionally tested for 
the ability to hydrolyse imipenem. All isolated V. metschnikovii and V. alginolyticus were 
examined for hemolytic activity on blood agar. A selection of 23 isolates were subjected to 
whole genome sequencing (WGS).  
A total of 64 V. alginolyticus, 38 V. metschnikovii, 24 V. anguillarum, seven V. aestuarianus 
and two presumptive V. cincinnatiensis were isolated. A high prevalence of phenotypic 
resistance to ampicillin (74 %), reduced susceptibility or resistance to oxolinic acid (32 %), 
aztreonam (19 %) and tobramycin (18 %), was observed. Preliminary analysis of assembled 
genomes revealed the presence of different classes of putative β-lactamase genes in examined 
isolates, topoisomerase IV subunit B (parE) conferring resistance to quinolones and 
quinolone resistance B proteins (QnrB) were detected in V. alginolyticus. Resistance-
Nodulation cell Division (RND) efflux pumps were detected in all examined species.  A tlh- 
and hlyA related gene was detected in all V. metschnikovii examined by WGS and a tlh related 
gene was found in all V. alginolyticus. 
The results from this study indicates a risk of exposure to potentially pathogenic vibrios 
through bathing or other marine recreational activities. Additionally, the occurrence of Vibrio 
spp. in both fish and bivalve molluscs indicates a risk of infection through consumption and 
handling of raw seafood, and the transfer of resistant bacteria to the human food chain.  
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Since the temperature is expected to increase further as a result of global warming, it is 






API = Analytical Profile Index 
APW = Alkaline Peptone Water 
bp = Base Pair 
CARB = Carbenicillin-hydrolysing  
CARD = The Comprehensive Antibiotic Resistance Database 
CCUG = Culture Collection University of Gothenburg 
cfu = Colony Forming Units 
CLSI = Clinical and Laboratory Standards Institute 
CTX = Cholerae Toxin 
DDD = Defined Daily Doses 
ECOFF = Epidemiological Cut-off 
EDTA = Ethylendiaminetetraacetic Acid 
EEA = European Environment Agency 
EUCAST = European Committee on Antimicrobial Susceptibility Testing 
GyrA = DNA gyrase subunit A 
GyrB = DNA gyrase subunit B 
HGT = Horizontal Gene Transfer 
HlyA = Hemolysin A 
IMR = Institute of Marine Research 
KOH = Potassium Hydroxide 
LPS = Lipopolysaccharide 
MALDI-TOF MS = Matrix Assisted Laser Desorption Time Of Flight Mass Spectrometry 
MHA = Mueller Hinton Agar 
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MIC = Minimum Inhibitory Concentration 
NFSA = Norwegian Food Safety Authority 
NIPH = Norwegian Institute of Public Health 
NMKL = Nordic Committee on Food Analysis 
NSC = Norwegian Sequencing Centre 
NVI = The Norwegian Veterinary Institute  
ParC = Topoisomerase IV Subunit A  
ParE = Topoisomerase IV Subunit B 
PBP = Penicillin-binding protein 
PCA = Plate Count Agar 
PCR = Polymerase Chain Reaction 
PCU = Population Correction Unit 
PMF = Peptide Mass Fingerprint 
QC = Quality Control 
QnrB = Quinolone resistance B protein 
RAST = Rapid Annotation using Subsystem Technology 
rcf = Relative Centrifugal force 
RND = Resistance-Nodulation cell Division  
RTX = Repeats-In-Toxin 
SST = Sea Surface Temperature 
TCBS = Thiosulfate Citrate Bile Sucrose 
TDH = Thermostable Direct Hemolysin 
TLH = Thermolabile Direct Hemolysin 
TRH = TDH-Related Hemolysin 
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TSA = Tryptic Soy Agar 
UoB = University of Bergen 
VBNC = Viable but non-culturable 
VCS = Vibrio ChromoSelect Agar 
VFDB = Virulence Factors Database 
WGS = Whole Genome Sequencing 
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1.1 Aim of the study 
 
The aim of this study was to increase the knowledge on the occurrence of human pathogenic 
Vibrio species in the Norwegian marine environment, and the occurrence of virulence- and 
antibiotic resistance genes in isolated strains. This is the first larger study on the occurrence of 
potentially pathogenic Vibrio spp. in the Norwegian marine environment since 2006, and to 
my knowledge the first on Norwegian pelagic fish. The work will add to the general 
knowledge on Vibrio bacteria, both those of relevance for seafood safety and non-human 
pathogenic species, and the role of the marine environment in the development and the spread 
of antibacterial resistance. The practical work in this project included sampling, isolation, 
obtaining pure cultures, characterisation, identification, antimicrobial susceptibility testing, 
determination of hemolytic activity, extraction of DNA and molecular methods to determine 







Figure 1: Sampling and analysis carried out throughout the project.  Isolation of Vibrio spp., pure cultures, Gram test, 
oxidase test, microscopy, analytical profile index (API) 20E, determination of hemolytic activity, antimicrobial susceptibility 
testing (AST), determination of minimum inhibitory concentration (MIC), carbaNP test, extraction of DNA and 
bioinformatical analysis was conducted at the Institute of Marine Research (IMR). Identification by MALDI-TOF MS was 
done at the Norwegian Veterinary Institute (NVI), rpoB- and 16S rRNA sequencing was done at the University of Bergen 





1.2 Vibrio species 
1.2.1 Genus Vibrio 
 
The genus Vibrio consists of Gram-negative bacteria belonging to the phylum Proteobacteria, 
class Gammaproteobacteria and family Vibrionaceae (Farmer, 2006;Williams et al., 2010). 
Bacteria belonging to the genus Vibrio are non-spore forming and typically appear as curved 
rods (Lunestad and Rosnes, 2008). All Vibrio species are oxidase positive, apart from Vibrio 
metschnikovii and Vibrio gazogenes (Lee et al., 1978;Farmer et al., 1988;Lunestad and 
Rosnes, 2018). Vibrios have the marine and estuarine environment as their natural habitat 
(Lunestad and Rosnes, 2008). They are also common on the surface of marine plants and 
animals, and they occur naturally in the intestine of marine animals (Lunestad and Rosnes, 
2018). Vibrios are facultative anaerobic, and NaCl stimulates the growth of all species and is 
an obligate requirement for some of the species (Adams, 2008). Their genomes are divided 
between two chromosomes, and recombination and horizontal gene transfer events are 
frequent and contribute to the evolution of Vibrio spp. (Baker-Austin et al., 2018). 
Vibrios are among the most common bacteria found in surface waters in the world and some 
species can cause infections in humans and animals (Vezzulli et al., 2015). At present, the 
genus Vibrio consists of 142 species (Bonnin-Jusserand et al., 2017). Among these, more than 
twenty Vibrio spp. have been described as pathogenic to animals (Lunestad and Rosnes, 
2018), and twelve have been recognized as human pathogens (Kokashvili et al., 2015). The 
human pathogens are Vibrio cholerae, V. parahaemolyticus, V. vulnificus, V. fluvialis, 
V. alginolyticus, V. damsela, V. furnissii, V. hollisae, V. mimicus, V. cincinnatiensis, 
V. metschnikovii and V. carchariae (Lunestad and Rosnes, 2018).  
The vibrios preferentially grow in warm (>18 °C), low salinity (<25 o/oo) seawater and 
brackish waters (Vezzulli et al., 2013). The human pathogenic Vibrio spp. show strong 
seasonality, and they are most abundant during the summer months when the waters are 
warmer (Vezzulli et al., 2015). Warming of low salinity marine environments is likely to 
support larger numbers of Vibrio populations and therefore increase the risk of infections 
(Baker-Austin et al., 2016). However, in the environment, vibrios can enter a state where they 
only retain basic metabolic processes when the conditions become less favourable, and can 
thus persist with low activity for an extended time period in the environment. This state is 
called viable but non-culturable (VBNC), and in this state they fail to grow on standard 
laboratory media and an enrichment step is required for isolation of the vibrios in this state 
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(Jorgensen and Pfaller, 2015;Fernández-Delgado et al., 2015). During warmer conditions, 
these cells will resuscitate. As a result, the cells can evade unfavourable conditions while they 
can return to their active state when the conditions again become favourable (Ayrapetyan et 
al., 2014). 
Human Vibrio infections typically occur as a result of ingestion of contaminated seafood, by 
exposure of wounds to seawater or through handling of seafood (Iwamoto et al., 2010). 
V. cholerae, V. parahaemolyticus, V. alginolyticus and V. vulnificus are most frequently 
causing disease in humans (Stavric and Buchanan, 1997;Baker-Austin et al., 2018).  
 
1.2.2 Human pathogenic Vibrio spp. and virulence factors  
 
Vibrio spp. are responsible for the majority of human infections attributed to the natural 
microbiota of aquatic environments and seafood (Baker-Austin et al., 2018). 
The pathogenicity of V. parahaemolyticus and V. cholerae is highly correlated to the presence 
of specific virulence genes.  
Throughout history V. cholerae has caused several pandemics. The epidemic capability of 
V. cholerae is linked to the presence of genes encoding the cholerae toxin (CTX), and the 
main serotypes possessing these genes are designated V. cholerae O1 and V. cholerae O139. 
Today, outbreaks of cholerae are often related to natural disasters and/or war-like situations 
where the hygienic and sanitary conditions are poor (Lunestad and Rosnes, 2008). An 
example of a recent outbreak of cholerae includes Yemen, where an ongoing war has 
damaged the water supply infrastructure, leading to water shortage and increased prices on 
clean water (Camacho et al., 2018). As of 1 March 2018, the total of suspected cholera cases 
in Yemen stands at 1 063 786 cases with 2 258 associated death since April 2017 (WHO, 
2018).  
Strains within the species V. cholerae can be subdivided into more than 200 serotypes based 
on the O antigen in the cell envelope (Lunestad and Rosnes, 2008;Baker-Austin et al., 2018). 
Strains not possessing the ctx genes are designated non-O1/non-O139 (Lunestad and Rosnes, 
2018). 
V. cholerae non-O1/non-O139 can cause both intestinal and extra intestinal infections, 
including wound and ear infections. The illness caused by these strains are often self-limiting 
and may include diarrhoea but can sometimes result in septicaemia. The virulence 
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mechanisms by V. cholerae non-O1/nonO-139 are mostly unknown, but in intestinal disease a 
heat stable enterotoxin has been described, in addition to a thermostable  hemolysin (TDH) 
(Ellingsen, 2008). 
Food poisoning caused by V. parahaemolyticus is exclusively associated with fish and other 
seafood. Occasional outbreaks have been reported in USA and Europe, while in Japan it is the 
most common cause of food poisoning (Adams, 2008). The pathogenicity of 
V. parahaemolyticus strains is strongly linked to their ability to produce a thermostable direct 
hemolysin (TDH), or a TDH-related hemolysin (TRH), which are encoded by tdh - and trh 
genes. TDH is a pore forming toxin with several biological activities, including hemolytic 
activity, cytotoxicity, cardiotoxicity, and enterotoxicity (Raghunath, 2014). TDH targets 
epithelial and intestinal cells and alters the ion flux in intestinal cells, causing a secretory 
response (Ghenem et al., 2017;Nishibuchi and Kaper, 1995). This is the cause of diarrhoea in 
patients with V. parahaemolyticus infections. TRH is a heat labile toxin and immunologically 
similar to TDH. Both TDH and TRH also activates Cl- channels, resulting in altered ion flux 
(Raghunath, 2014). However, during a study in 2005, 6 % of clinical isolates lacked both tdh -  
and trh genes, suggesting the presence of other virulence determinants in V. parahaemolyticus 
(Lynch et al., 2005). In rare cases, V. parahaemolyticus can cause wound infections, ear 
infections or septicaemia that can be life threatening to vulnerable individuals (Letchumanan 
et al., 2014). 
Together with V. cholerae and V. parahaemolyticus, V. vulnificus is a normal inhabitant of the 
marine environment. V. vulnificus is divided into three biotypes, 1, 2 and 3. All three biotypes 
are opportunistic human-pathogens, but biotype 2 is also a fish pathogen (Roig et al., 2018). 
There are two major manifestations of V. vulnificus infections, wound infection and 
septicaemia. This opportunistic pathogen primarily cause infection in people with a 
compromised immune system and/or underlying disease. Especially people suffering from 
liver or blood related disorders, often resulting from alcoholism are at risk. The ability to 
cause disease in humans is related to the production of a polysaccharide capsule that enables 
the bacterium to resist phagocytosis, lipopolysaccharide (LPS) which is to cause tissue 
damage by stimulation of nitric oxide synthase, which then release nitric oxide (Ellingsen, 
2008). The genetic basis for human virulence is only partial known, although a number of 
studies suggest that all strains of V. vulnificus, regardless of their origin, may be able to cause 
infections in humans (Roig et al., 2018). A number of other virulence factors, such as 
hemolysin, proteases and flagella have been examined, but none of these have been 
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conclusively linked with pathogenesis (Ellingsen, 2008). The ability of V. vulnificus to infect 
fish is dependent on a virulence plasmid (PVvBt2) that is only present in biotype 2 strains 
(Roig et al., 2018). 
However, several other Vibrio spp., such as V. alginolyticus, V. fluvialis, V. mimicus, 
V. metschnikovii, V. furnissii, V. hollisae and V. damsela, are considered to be lower risk 
organisms, but can cause infections in humans (Austin, 2010;Adams, 2008).  
The species V. alginolyticus can cause ear - and wound infections, as well as gastroenteritis 
(Austin, 2010;Mustapha et al., 2013;Baker-Austin et al., 2016;Adams, 2008). This species can 
produce three different hemolysins, TRH, TDH and Thermolabile Direct Hemolysin (TLH) 
(Hernández-Robles et al., 2016;Ellingsen, 2008). V. metschnikovii have been implicated in 
different types of infections, such as wound infections, pneumonia, bacteremia and 
gastroenteritis (Linde et al., 2004;Dalsgaard et al., 1996;Wallet et al., 2005;Hardardottir et al., 
1994). Hemolysin and verotoxin are suggested to be the virulence factors of this Vibrio sp. 
(Matté et al., 2007). Other vibrios, such as V. fluvialis, V. furnissi and V. hollisae can cause 
diarrhoea, while V. mimicus and V. damsela in addition to diarrhoea, can cause wound 
infections (Adams, 2008).  The infections caused by the human pathogenic Vibrio spp. are 





Table 1: Human pathogenic Vibrio spp. and the infections they can cause. GI tract: Gastro intestinal tract. ++: most 
common site of infection. +: other sites of infection. (+): rare sites of infection. -: no reported infections (Adams, 2008;A. 
Daniels and Shafaie, 2000;West, 1989;Austin, 2010;Deshayes et al., 2015;Oliver, 2005;Chowdhury et al., 2016;Hao et al., 
2015;Glenn Morris, 2018;Roig et al., 2018;Chiang and Chuang, 2003;Kim et al., 2003;Katz, 1988;Mizuno et al., 2009;Linde 
et al., 2004;Hardardottir et al., 1994;Dalsgaard et al., 1996;Macarena Pariente et al., 2008;Jensen and Jellinge, 2014;Jean-
Jacques et al., 1981;Mustapha et al., 2013;Hansen et al., 1993;Baker-Austin et al., 2018;Lunestad and Rosnes, 2018) 
Species GI tract Wound Ear Sepsis Lung Meningitis 
V. cholerae 
O1/O139 
++ + - - - - 
V. cholerae non-
O1/O139 
++ + + + - (+) 
V. parahaemolyticus ++ + + (+) (+) (+) 
V. vulnificus + ++ - ++ (+) (+) 
V. alginolyticus + ++ + (+) - - 
V. metschnikovii (+) (+) - (+) (+) - 
V. fluvialis ++ (+) (+) - - - 
V. damsela - ++ - - - - 
V. furnissii + - - - - - 
V. mimicus ++ + + + - - - 
V. hollisae ++ + - (+) - - 
V. cincinnatiensis - - - (+) - (+) 
V. carchariae - + - - - - 
 
 
1.2.3 The occurrence of Vibrio spp. in Europe and Norway  
 
During the last two decades, reported infections have increased in areas not usually associated 
with these bacteria, including temperate and cold regions, such as US Pacific Northwest, 
South America, and Northern Europe (Baker-Austin et al., 2016).  Previous studies have 
shown that a regime shift warming has caused increased occurrence of Vibrio spp. in the 
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environment, and that Sea Surface temperatures (SST) > 18 ˚C is a critical threshold for 
triggering infections (Martinez-Urtaza et al., 2018).  
According to the European Environment Agency (EEA), one of the primary effects of climate 
change in the European seas are increased SST, and this may facilitate the spread of water-
borne diseases, such as Vibriosis (EEA, 2017). It has been estimated that the  global SST in 
average is 1 °C higher today than it was 140 years ago (Vezzulli et al., 2015).  
There are no common mandatory notification systems for Vibrio infections, and accurate 
estimates of the number of Vibrio infections occurring in Europe is thus not available (Leroux 
et al., 2015). 
 
The increase in outbreaks of Vibrio-associated human illness caused by V. parahaemolyticus, 
V. vulnificus and V. cholerae non-O1/non-O139 in several European countries, including 
reported infections in Sweden and Denmark, has been linked to the increase in SST. Warming 
of low salinity marine environments, which can occur in Norway during the summer, is 
shown to support larger numbers of Vibrio spp. and consequently increase the risk of 
infections.  
Domestically acquired Vibrio infections are rare in northern Europe, however during a heat 
wave in northern Europe the summer of 2014, an unusually high number of Vibrio infections 
was reported in Finland and Sweden. A total of 89 infections was reported, of which 70 were 
caused by V. cholerae non-O1/non-O139, four by V. parahaemolyticus, three by 
V. alginolyticus, two by V. vulnificus, one by V. mimicus, and eight cases were caused by 
unspecified Vibrio sp. (Baker-Austin et al., 2016).  
Potentially pathogenic Vibrio spp. have been detected in biofilm communities on 
microplastics in the oceans, and these particles can be spread over long distances by waves 
and currents. The composition of these biofilm communities varies with season and 
geographical location. It has been suggested that these particles can serve as vectors for the 
dispersal of human pathogenic Vibrio spp. between distant geographical locations (Kirstein et 
al., 2016). It has also been suggested that pathogenic V. parahaemolyticus have been spread 




Little is known regarding the occurrence of Vibrio species in Norwegian waters, but 
V. parahaemolyticus, V. alginolyticus, V. cholerae and V. vulnificus have all previously been 
isolated. During a study by Gjerde and Bøe conducted in 1981, V. parahaemolyticus was 
isolated from mussels in July and August, with sea temperature from 15-16 °C. In this period 
16 mussels where examined and V. parahaemolyticus was isolated from five of these (30 %). 
In the same period V. parahaemolyticus were also isolated from four (25 %) of 16 samples 
from bottom sediments.  V. alginolyticus were regularly isolated from mussels, seawater, 
bottom sediments and fish, with the highest number of bacteria isolated in July, August and 
September (Gjerde and Bøe, 1981). During a study conducted in the period 2001 – 2006, a 
total of 1280 seafood and water samples were examined with respect to the presence and level 
of V. parahaemolyticus, V. cholerae and V. vulnificus. During this study, the three species 
were all detected in blue mussels, almost exclusively during summer months, but the levels 
were <100 cfu/g. One crab and one oyster sample tested positive for the presence of the three 
species. V. parahaemolyticus, V. cholerae and V. vulnificus were also detected in water 
samples with maximum levels of 30 cfu/ml. In 13 of the V. parahaemolyticus positive 
samples the trh gene was detected, while all of the V. cholerae isolates were non-O1/non-
O139 (Ellingsen, 2008). However, during the summer of 2018, several bathing associated 
Vibrio infections were reported in Southern Norway. A total of six serious Vibrio infections 
and 27 mild cases of wound- and ear infections caused by Vibrio spp. were reported to the 
Norwegian Institute of Public Health (NIPH) (NIPH, 2018a). Four of the serious infections 
were caused by V. vulnificus (NIPH, 2018b). All the reported infections occurred after bathing 
along the South coast of Norway and in areas along Oslofjorden (NIPH, 2018a). The summer 
of 2018 was unusually warm in Norway, with an average temperature 1.8 ˚C above normal. 
The highest average temperature was recorded in the eastern parts of Norway with an average 
temperature 3-4 ˚C above the normal average temperature (MET, 2018;ECDC, 2019). This 
corresponds with literature showing an increase in reported domestically acquired Vibrio 
infections in northern Europe in “heatwave” years (Leroux et al., 2015). During the summer 
of 2018, the Norwegian Food Safety Authority issued a warning against eating raw oysters 
caught in Oslofjorden, along the coast of Telemark and the South coast of Norway due to the 
increased risk of foodborne Vibrio infections. The warning applied until the water temperature 




1.3 Bacteria of fish and bivalve molluscs 
  
The aquatic environment represents the largest part of the planet and the oceans contain 
several species of microorganisms adapted to these habitats. Sea water contain approximately 
106 bacterial cells/ml water (Bergh et al., 1989;Azam et al., 1983). Bacteria isolated from the 
open oceans often have a physiological requirement for salt, grow best at relatively low 
temperatures and are adapted to the low concentrations of available organic and nitrogenous 
compounds present in the oceans (Adams, 2008). 
Fish caught from the open sea will have a microbiota which reflects their environment, and 
consequently, fish caught from cold water will predominantly contain psychrophilic and 
psychrotrophic bacterial species (Adams, 2008). Live fish in temperate waters have bacteria 
present in the mucoid layer of their skin (102-107 cfu/cm2), their gills (103-107 cfu/g) and the 
highest concentration is found in their intestine (107-109 cfu/g) (Lunestad and Rosnes, 2018). 
The majority of shellfish feed by filtering out particles from the seawater, and therefore 
bacteria present in their environment will be concentrated. The seas around the coasts are also 
influenced by inputs of terrestrial and freshwater bacteria, and by human activities. The sea 
has been a convenient dump site for sewage and waste products, and this has had a 
detrimental effect on coastal waters. Many shellfish used for food grow in these coastal 
waters, and if these waters have been contaminated by sewage, the filter feeders may contain 
high concentrations of enteric bacteria (Adams, 2008). In warmer waters, unpolluted water 
may even contain high numbers of V. parahaemolyticus and these may be concentrated by the 
shellfish and form a stable part of the enteric flora of some shellfish (Adams, 2008). 
 
1.4 Antimicrobial agents 
1.4.1 The history of antibiotics 
 
The development of antibiotics has been one of the major medical achievements in the 20 th 
century, and since they were first introduced on a larger scale in the 1940`s, millions of lives 
have been saved (Marti et al., 2014). The first true antibiotics introduced were penicillin and 
streptomycin, antimicrobial agents produced by microorganisms. Penicillin was first isolated 
from the fungus Penicillium chrysogenum, and streptomycin from the soil bacterium 
Streptomyces griseus  (Madigan et al., 2015;Marti et al., 2014;Yazdankhah et al., 2013). The 
period between the 1950`s and 1970`s was the golden era of discovery of antibiotics, with no 
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new classes discovered since then, and one-half of the antibiotics commonly used today were 
discovered in this period (Aminov, 2010;Davies, 2006). More than 350 agents have reached 
the marked as antimicrobials, these are natural and semisynthetic antibiotics, and strictly 
synthetic chemicals (Demain, 2009).  
 
1.4.2 Mechanisms of action  
 
Antibiotics can be ranged from a narrow to a broad spectrum of activity, where the broad-
spectrum antibiotics are effective against a larger group of bacteria, while the narrow-
spectrum antibiotics are effective against a limited range of bacteria. These agents can again 
be either bacteriostatic or bactericidal. Bacteriostatic agents are typically inhibitors of 
important biochemical process, e.g. protein synthesis, by binding weakly to their target. If the 
agent is removed, the cells can keep growing. Bactericidal agents bind tightly to their target 
and kills the cell (Madigan et al., 2015). Antibiotics are categorized in groups based on their 
mechanism of action (Kapoor et al., 2017): 
 
Antibiotics targeting the cell wall: 
The bacterial cell is surrounded by a cell wall which amongst other consists of peptidoglycan. 
Peptidoglycan is a polysaccharide composed of N-acetylglucosamine and N-acetylmuramic 
acid, and a few amino acids. This forms a stiff layer and is primarily responsible for the 
strength of the cell wall. Long chains of peptidoglycan are synthesized next to each other and 
forms a sheet that surrounds the cell. The chains are connected by cross-links between short 
peptides (Madigan et al., 2015;Kapoor et al., 2017;Vollmer et al., 2008). The Gram-positive 
cell wall mainly consists of peptidoglycan, while the Gram-negative cell wall only consists of 
a small amount of peptidoglycan as most of the cell wall is composed of an outer membrane. 
In Gram-negative cells, a region called the periplasm is located between the outer- and the 
cytoplasmic membrane, and the periplasm contains several classes of proteins (Madigan et al., 
2015). Some classes of antibiotics work by inhibiting the cell wall synthesis. Penicillin-
binding proteins (PBPs) are enzymes involved in the polymerization of glycan strands and the 
cross-linking between the glycan strands (Sun et al., 2014). Antibiotics which inhibit the cell 
wall synthesis can work by binding to the PBPs, and this inhibits the synthesis of new 
peptidoglycan. This disruption of the peptidoglycan layer leads to cell lysis (Kapoor et al., 
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2017).  Penicillins and cephalosporins are classes of β-lactam antibiotics that work by 
inhibiting the synthesis of a functional bacterial cell wall (Madigan et al., 2015) 
Inhibitors of the protein synthesis: 
In the protein synthesis, the information in the bacterial DNA is first used to synthesize 
mRNA. This process is called transcription. Next, in the translation, the ribosome synthesizes 
the proteins in mRNA (Kapoor et al., 2017). The protein synthesis is a continuous process, but 
can be broken down to three steps, initiation, elongation and termination. 
The prokaryotic ribosome, 70S, consists of 30S- and 50S subunits which makes up intact 70S 
ribosomes (Madigan et al., 2015). Both the 30S- and 50S subunits are essential for the 
biosynthesis of proteins, and different agents can inhibit this process by targeting either one of 
the subunits. Among the classes of antibiotics which work by inhibiting this process are the 
tetracyclines (30S), aminoglycosides (30S) and the macrolides (50S) (Kapoor et al., 2017).  
Inhibitors of DNA replication: 
The quinolones can disturb the bacterial DNA replication by interfering with bacterial DNA 
gyrase (topoisomerase II), an enzyme responsible for the supercoiling of DNA (Hawkey, 
2003). This step is required for packaging of DNA in the bacterial cell (Madigan et al., 2015). 
DNA gyrase consists of two subunits, A (GyrA) and B (GyrB). The A subunit carries out the 
nicking of DNA, while the B subunit introduces negative supercoils, and the A subunit reseals 
the strands. The quinolones binds the A subunit, and by this mechanism they disrupt the 
cutting and resealing of its strand (Kapoor et al., 2017). DNA gyrase is the primary target for 
quinolones in Gram-negative bacteria, while a structurally similar protein, topoisomerase IV, 
is the primary target for quinolones in Gram-positive bacteria (Kohanski et al., 2010). 
Topoisomerase IV consists of the subunits A (ParC) and B (ParE) (Madigan et al., 2015). 
Inhibitors of essential metabolic steps: 
Growth factors are specific chemical substances required by an organism that is unable to 
synthesize them. These organisms are therefore dependent on an outside source for these 
substances. Growth factor analogues are synthetic compounds that are structurally similar to a 
growth factor, but the differences between the analogue and the growth factors prevent the 
analogue from functioning in the cell. As a result, the cell metabolism is disrupted (Madigan 
et al., 2015).  The sulphonamides and trimethoprim are antibacterial agents which inhibit 
steps in the folic acid metabolism. Sulphonamide is an analogue of p-aminobenzoic acid 
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(PABA), a part of folic acid and a nucleic acid precursor. By this mechanism, the 
sulphonamides block the synthesis of folic acid and thereby inhibit the synthesis of nucleic 
acid (Madigan et al., 2015;Kapoor et al., 2017).  Trimethoprim is a structural analogue which 
binds to bacterial dihydrofolate reductase, and thereby blocking the reduction of dihydrofolate 
to tetrahydrofolate, the active form of folic acid (D Byron May et al., 2018;Gleckman et al., 
1981). Sulphonamide and trimethoprim are often used in a combination as they block two 
sequential steps in the folic acid synthesis pathway (Madigan et al., 2015).  
 
1.4.3 The usage of antibiotics in Norway 
 
The use of antimicrobial agents in Norway is low compared to many other countries. Norway 
is in a unique position with low levels of resistant bacteria in animals, in food and in feed.  
Only 10 % of all antibiotics used in Norway is used for terrestrial animals and only 0.5 % for 
aquaculture. However, the situation may change if the use of antimicrobial agents in Norway 
increases or resistant strains develop or are imported from abroad (NORM/NORM-VET, 
2016). 
The total sale of antibiotics in Norway in 2017 was 13.8 defined daily doses (DDD)/1000 
inhabitants/ day, in both primary care and in institutions. The major classes of antibacterial 
agents for clinical use in Norway is penicillins with extended spectrum, β-lactamase sensitive 
penicillins and tetracyclines (NORM/NORM-VET, 2017). 
In 2017, the overall sales of antibacterial agents for use in veterinary medicine was 5 587 kg 
active substance (NORM/NORM-VET, 2017).  For terrestrial food producing animals, 
penicillins is the most selling class, and almost exclusively benzylpenicillin. In aquaculture, 
florfenicol (269 kg active substance), oxolinic acid (343 kg active substance) and flumequine 
(<0.05 kg active substance) are the only antibacterial agents used (NORM/NORM-VET, 
2017).   
From 1987 to 2017 the sales of antibacterial agents used in aquaculture has decreased by 
99.9 %, from 876 mg/PCU to 0.5 mg/PCU in 2017. This reduction is mainly attributed to the 
introduction of effective vaccines against bacterial infections in Atlantic salmon and rainbow 
trout, along with the prevention of bacterial infections and the spread of these 
(NORM/NORM-VET, 2017).  
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In 2015, the Norwegian government launched a national strategy to reduce the use of 
antibiotics in humans by 30 % and by 10 % in food producing animals within 2020. The 10 % 
reduction of antibiotics used in food producing animals was reached in 2017 (Ministry of 
Agriculture and Food, 2018). 
 
1.5 Antimicrobial drug resistance 
1.5.1 Development of antimicrobial drug resistance 
 
Antimicrobial drug resistance is defined as the acquired ability of a microorganism to resist 
the effects of an antimicrobial agent to which it is normally susceptible to (Madigan et al., 
2015).  
Shortly after the introduction of penicillin in the 1940`s resistance against this antibiotic 
became a clinical problem, and in the 1950`s many of the advances made in the treatment of 
bacterial infections became threatened (Ventola, 2015). However, antibiotic resistance is not a 
modern phenomenon, bacteria originated over 3.8 billion years ago, and as antibiotics are 
natural products produced by bacteria and fungi, antibiotics are at least hundreds of millions 
of years old (Wright and Poinar, 2012;von Wintersdorff et al., 2016). As a result, bacteria 
must have been exposed to antibiotics and their derivates directly or indirectly for the same 
amount of time. Antibiotic producers must co-evolve mechanisms to protect them self from 
the toxic effect of their self-produced antibiotics (Wright and Poinar, 2012). Most antibiotics 
used are derived from the Actinomycetes, with the most significant genus for antibiotic 
production being Streptomyces. This genus is responsible for the production of antibiotics 
such as streptomycin, tetracycline, chloramphenicol, erythromycin and vancomycin. These 
organisms have to be able to avoid the toxic effect of their own metabolites, and therefore, 
they are resistant to these antibiotics (Perry et al., 2016). 
Today, antimicrobial resistance is an emerging problem worldwide, leading to increased 
morbidity and mortality (NORM/NORM-VET, 2016). There is a strong correlation between 
the usage of antibiotics and the occurrence of resistant bacteria (NORM/NORM-VET, 2016), 
and the extensive use of antibiotics, both clinically (Llor and Bjerrum, 2014;Shallcross and 
Davies, 2014;Webster, 2017;Marti et al., 2014) and in food producing animals (Martin et al., 
2015;Santos and Ramos, 2018;Tang et al., 2017;Marti et al., 2014), is a driving force of the 
evolution of resistant bacteria. This leads to drug-sensitive competitors being removed, while 
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the resistant strains are left behind to re-produce as a result of natural selection (Ventola, 
2015). 
The World Health Organization (WHO) has ranked antimicrobial resistance as one of the 
biggest threats to global health, food security and development. Resistance against 
antimicrobial agents is rising to dangerously high levels all over the world, and a growing list 
of infections, such as pneumonia, tuberculosis, septicaemia, gonorrhoea and food poisoning 
are becoming harder to treat as antimicrobial agents become less effective (WHO, 2017a). 
 
1.5.2 Dissemination of antimicrobial resistance 
 
Both resistant bacteria, antibiotic residues and genetic resistance determinants are spread to 
the adjacent environments. The majority of consumed antibiotics are excreted unchanged and 
can then be introduced to the environment, either directly or through e.g. waste streams (von 
Wintersdorff et al., 2016). New methods for high-throughput sequencing tools have revealed 
that an intrinsic resistome exists, including sequences normally belonging to bacterial 
metabolic networks that can participate in resistance towards antimicrobial agents. These 
“pre-resistance” genes can evolve to new resistance mechanisms if they reach an environment 
with a high concentration of antibiotics (Marti et al., 2014).  
Resistance to antibiotics can be disseminated through the spread of resistant bacteria 
themselves, among bacteria through vertical transmission (the genome is transferred to 
daughter cells during binary fission) or by horizontal gene transfer (HGT). HGT is not limited 
to closely related bacteria, it can also take place between bacteria from different species 
and/or ecological niches (NORM/NORM-VET, 2016). At least three mechanisms for HGT 
are known, transformation, conjugation and transduction (Madigan et al., 2015).  
Acquisition of foreign DNA from HGT is one of the most important drivers for bacterial 
evolution, and hence it is frequently responsible for the development of antimicrobial 
resistance.  
The role of the aquatic environment in the development and dissemination of antimicrobial 
resistance is largely unknown. A large portion of antibiotics consumed by humans, and used 
for livestock, is released in an active biological form through urine and feces (Osunla and 
Okoh, 2017). Human and animal potentially pathogenic bacteria are constantly released with 
waste water into the marine environment, and many of these organisms harbour genes 
encoding antibiotic resistance. These are able to spread among the members of microbial 
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communities in water and soil (Baquero et al., 2008). The use of antimicrobial agents in 
agriculture leads to discharge of residual antibiotics and resistance genes via run-off from land 
to the marine environment (Berglund, 2015). Waste streams and treatment plants are 
considered to be hotspots for the dissemination of antimicrobial resistance, since resistance 
genes, mobile genetic elements and antibiotic selection pressure are introduced. The antibiotic 
compounds are poorly removed in the treatment plants, and as a result, they can spread further 
(von Wintersdorff et al., 2016).  Even though the antibiotic concentrations in non-clinical 
settings are generally low, the selection of resistant bacteria can occur at extremely low 
antibiotic concentrations, like those concentrations found in natural environments as soil and 
the aquatic environment (Marti et al., 2014). Therefore, the use of antimicrobial drugs and 
resistance in one ecological compartment can have consequences for the occurrence of 
resistance in another compartment (NORM/NORM-VET, 2016). Multidrug resistant strains 
have been detected in coastal areas dedicated to fish farming (Labella et al., 2013). 
 
1.5.3 Biochemical and molecular resistance mechanisms 
 
Bacteria possess three main strategies for resistance. Individual bacterial isolates often 
possess more than one resistance mechanism, and individual antimicrobials can be affected by 
different mechanisms in different bacteria. Bacteria may also have intrinsic resistance to 
certain agents from inherent structural or metabolic properties of the bacterial species (Munn, 
2011).  
Modification of the target binding site: 
Bacteria can develop antimicrobial resistance by modification of the agents binding site, and 
in this way avoid the action of the antibiotic. These alterations often result from spontaneous 
mutations of a bacterial gene on the chromosome and leads to reduced affinity for the 
antibiotic molecule (Kapoor et al., 2017;Munita and Arias, 2016). An example of this is 
alteration in the PBPs, which results in reduced affinity for β-lactam antibiotics (Kapoor et al., 
2017). 
Reduced permeability and Efflux pumps: 
Many antibiotics have intracellular targets, or for Gram-negative bacteria, in the periplasm. 
Because of this, the antibiotic molecule must pass the outer and/or cytoplasmic membrane to 
exert its effect (Munita and Arias, 2016). These molecules can be transferred by diffusion 
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through porins, diffusion through the bilayer and by self-uptake. The porin channels are 
located in the outer membrane in Gram-negative bacteria, and the small hydrophilic 
molecules, such as β-lactams can only cross the outer membrane through porins. The decrease 
in number of porins leads to decreased influx of β-lactams into the periplasm, and thereby 
resistance against such antibiotics (Kapoor et al., 2017). 
Alterations in the membrane transport proteins can also lead to active efflux of the antibiotics, 
the molecule is removed from the cell in the same speed as they enter before they reach their 
target (Kapoor et al., 2017). The efflux pumps can be either substrate specific (specific for a 
particular antibiotic), or they can have a broad substrate specificity (Munita and Arias, 2016). 
Enzymatic degradation: 
One of the most successful strategies to avoid the effect of antibiotics, is by producing 
enzymes that can inactivate the antimicrobial agent. These enzymes can break down the 
antibiotic molecule, and in this way the agent become ineffective (Munita and Arias, 2016). 
One of the main enzymes that inactivate antibiotics are β-lactamases, of which some, such as 
New Delhi metallo-β-lactamase (NDM-1) are able hydrolyse nearly all β-lactam antibiotics 
with ester- and amide bonds (e.g. penicillins, cephalosporins and carbapenems). There are 
about 300 known β-lactamases. Other enzymes with the ability to inactivate antibiotics are 
aminoglycoside-modifying enzymes and chloramphenicol acyltransferases (Kapoor et al., 
2017).  
 
1.5.4 Antibiotic resistance and Vibrio spp. 
 
As vibrios are naturally occurring in the marine environment, these bacteria can acquire 
resistance genes from other bacteria in the environment. Many of the genetic determinants 
that confer resistance to antibiotics are located on plasmids and transferable to other bacteria 
in the environment through vertical gene transfer or HGT (Osunla and Okoh, 2017). For this 
reason, the environmental vibrios may serve as a reservoir for the spread of antibiotic 
resistance due to HGT (Zhang et al., 2012). The abundance of Vibrio spp. in the marine 
environment makes them interesting for monitoring the challenges that the ecosystem faces, 
such as the impact of using antibiotics and chemicals in aquaculture, agriculture and clinical 
facilities  due to the spread of residues to the environment (Banerjee and Farber, 2018).  
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In some regions, excessive use of antibiotics in the aquaculture and agriculture industry, has 
led to the development of multidrug resistance and high levels of resistance to several 
antibiotics among pathogens associated with seafood, such as Vibrio spp. In the recent years 
the presence of antibiotic resistance genes detected in Vibrio species have increased, including 
the β-lactam and penicillin resistance genes penA and blaTEM-1, genes encoding resistance 
against chloramphenicol, such as floR, catI and catII, and several tet genes encoding 
resistance against tetracycline (Letchumanan et al., 2015).  
In 2004, V. anguillarum strains showing reduced susceptibility to quinolones was isolated 
from Atlantic cod reared in Norway. The examination of these strains revealed mutations in 
the gyrA and parC genes and these mutations were responsible for the quinolone resistance 
(NORM/NORM-VET, 2007). 
Environmental Vibrio spp. isolated from retail shrimp and reared fish have also shown 
resistance or reduced susceptibility to cefepime, tetracycline, aztreonam, streptomycin, 
gentamicin, tobramycin, cefazolin, cefuroxime and trimethoprim, and V. vulnificus, 
V. alginolyticus, V. harveyi and V. parahaemolyticus isolated from seafood have shown high 
prevalence of resistance to ampicillin (Hernández-Robles et al., 2016;Pan et al., 2013;Li et al., 
1999).  
An intrinsic resistance mechanism against penicillins have been detected in Vibrio spp. In 
V. parahaemolyticus, a histidine kinase/response regulator pair (VbrK/VbrR) that controls the 
expression of a β-lactamase have been detected. VbrK detects β-lactam antibiotics via direct 
binding and the signal is transmitted to VbrR, to control the expression of a carbenicillin-
hydrolysing (CARB) β-lactamase gene (blacarb-17). VbrK is present in almost all Vibrio spp. 
and the residues responsible for specific recognition of lactams are conserved in different 
Vibrio species. The gene coding  β-lactamase have also been found in many Vibrio spp., 
including V. harveyi, V. alginolyticus and non-O1/non-O139 V. cholerae, and the direct 
recognition of β-lactam antibiotics by Vbrk can be a well conserved mechanism to induce the 
β-lactamase gene in Vibrio spp. (Chiou et al., 2015;Li et al., 2016). 
The correlation between the use of antimicrobial agents and development of resistance leads 
to differences in the frequency of resistant strains depending on geographical use of 
antibiotics.   
Little recent data regarding the antimicrobial susceptibility of Vibrio species in Northern 
Europe has been found. However, in 2015 Bier et al. performed a study were the 
antimicrobial susceptibility of V. vulnificus and V. cholerae isolated in Germany was 
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examined. The susceptibility of environmental strains obtained from German coastal and 
estuarine waters, clinical strains and isolates from retail seafood were investigated. The results 
showed that most of the antimicrobial agents recommended for treatment of V. vulnificus and 
V. cholerae non-O1/non-O139 were effective. However, among V. vulnificus isolates, 
resistance against aminoglycosides was found, and for V. cholerae resistance against 
aminopenicillins and aminoglycosides was observed. In this study, the results indicated the 
presence of a β-lactamase with carbapenem hydrolysing activity in four environmental V. 
cholerae non-O1/non-O139 isolates. The author of this publication highlights the need for 
systematic monitoring of antimicrobial susceptibility in potentially pathogenic Vibrio spp. in 
Europe, as carbapenems are considered last line agents for treatment of multidrug resistant 
Gram-negative bacteria (Bier et al., 2015).  
During an investigation of the antimicrobial susceptibility of 99 strains of V. cholerae non-
O1/non-O139 isolated from wastewater and shellfish in 2000-2001 in France, resistance 
towards one antimicrobial agent (streptomycin, sulphonamides or ampicillin) was detected in 
55 % of the tested strains, while multidrug resistance was detected in 6 % of the strains. All 
the multidrug resistant strains were isolated from cockles and showed resistance to all three 
agents (Baron et al., 2017).  
 
1.6 Identification of Vibrio spp. 
1.6.1 Analytical Profile Index 20E (API 20E) 
 
The API 20E test kit is used for identification of Enterobacteriaceae and other non-fastidious 
Gram-negative bacteria (bioMèrieux, 2002). The system consists of dehydrated chemicals in a 
set of 20 reaction wells which are inoculated with a bacterial suspension. During incubation, 
bacterial metabolism produces colour changes. These colour changes are either spontaneous 
or revealed by addition of reagents to the wells. Based on the results from the biochemical 
tests, the tested isolates are given a seven-digit number which is used to identify the isolates 
using the apiwebTM database.  The API 20E database contains six Vibrio spp.: V. 






1.6.2 Matrix Assisted Laser Desorption Time Of Flight Mass Spectrometry (MALDI-TOF 
MS) 
 
Matrix Assisted Laser Desorption Time Of Flight Mass Spectrometry (MALDI-TOF MS) is 
used for the analysis of biomolecules, such as proteins and peptides (Bishop et al., 2013). 
The samples for analysis by MALDI-TOF MS is prepared by mixing with a matrix, an energy 
absorbent, organic compound, on a stainless-steel target plate. When the matrix is dried, it 
becomes crystalized, and the sample within the matrix will co-crystallize (Singhal et al., 
2015). The sample is then ionized and vaporized by a laser. This generates singly protonated 
ions from analytes in the sample. The protonated ions generated are accelerated along the 
column toward a detector by an electric field. The time of flight (TOF) for each ion depends 
on their mass-to-charge-ratio (m/z).  The charged analytes are then detected and measured 
(Madigan et al., 2015). Based on the TOF information, a characteristic spectrum, a peptide 
mass fingerprint (PMF), is generated for the analytes in the sample. Identification of microbes 
by MALDI-TOF-MS is done by either comparing the PMF of an unknown organism with the 
PMFs in a database, or by matching the masses of biomarkers of unknown organisms with the 
proteome database (Singhal et al., 2015). 
 
1.6.3 rpoB sequencing 
 
Sequencing of the 16S ribosomal RNA (rRNA) gene is widely used in microbiology to 
identify prokaryotic organisms. This small subunit rRNA gene is the recognized gold standard 
for estimating the diversity in microbial communities (Vos et al., 2012). However, the genus 
Vibrio contains a large number of closely related species with 16S rRNAs differing in 
nucleotide sequence from less than 1 % up to 6 % (Moreno et al., 2002), rendering 16s rRNA 
sequencing less reliable for identification to the species level.  The number of known 
Vibrio spp. continues to rise, thus it becomes more likely that sequence variation in the 16s 
rRNA gene will no longer be sufficient alone as a target for differentiation of closely related 
Vibrio spp. (Hoffmann et al., 2010). 
The rpoB gene has been suggested as a potential biomarker to overcome the high 
conservation of the 16S rRNA gene. rpoB is a gene encoding the beta subunit of RNA 
polymerase. This gene is homogeneous within cells because it is a single copy gene, and 
therefore it has advantages over the 16S rRNA gene (Ki et al., 2009). Sequencing of the rpoB 
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gene has proved to be a valuable tool for identification of Vibrio spp. (Schirmeister et al., 
2014;Tarr et al., 2007;Schwartz et al., 2017). 
 
1.7 Antimicrobial susceptibility testing  
1.7.1 Disk diffusion  
 
Disk diffusion is a method used for antimicrobial susceptibility testing in many clinical 
laboratories (Balouiri et al., 2016).  
When an antibiotic disk with a known concentration of an antibiotic agent is placed on a 
Mueller Hinton agar (MHA) plate inoculated with a bacterial suspension, the agent will start 
to diffuse into the agar and inhibit the growth of the microorganism. The speed of the 
diffusion into the agar is not as quick as the speed of extraction of the agent from the disk. As 
a result, the concentration of the antibiotic will be highest closest to the disk and decrease 
with increasing distance, and an inhibition zone will form around the agent. How fast the 
agent diffuses in the agar depends on the agents solubility in the medium and the molecular 
weight of the agent. This results in unique breakpoints for each antimicrobial agent, and this 
makes it possible to determine the tested isolates susceptibility towards the agents by 
measuring the inhibition zones (Hudzicki, 2009).  
International organizations, such as Clinical (CLSI) and European Committee on 
Antimicrobial Susceptibility Testing (EUCAST), have developed standardized protocols for 
the disk diffusion method for different groups of bacteria, and breakpoints which makes it 
possible to determine the test organisms susceptibility towards the tested agents. Based on 
these breakpoints, the tested bacteria can be categorized as sensitive (S), intermediate 
susceptible (I) or resistant (R) to the tested agents.  
The tested bacteria can also be classified as wild-type (WT) or non-wild-type (NWT) to 
antibacterial agents. A WT strain can be defined as a bacterium without an acquired resistance 
mechanism or mutation causing resistance to the tested antibacterial agent, while an NWT 
strain has an resistance mechanism to the tested agent (Turnidge and Paterson, 2007). The 
categorization as WT/NWT is based on epidemiological cut-off values (ECOFF). ECOFFs are 
useful when clinical breakpoints not yet have been defined and could detected development of 
resistance early. These values are not necessarily clinically significant (Toutain et al., 2017).  
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As many of the vibrios are halophilic bacteria, they may have a higher salt requirement than 
the 0.86 % found in MHA, and it is recommended by the CLSI to test obligate halophilic 
bacteria on MHA supplemented with 1 % NaCl (Guérin-Faublée et al., 1995;CLSI, 2006). 
 
1.8 Genomic analysis 
1.8.1 Whole genome sequencing (WGS) 
 
Whole genome sequencing (WGS) is a method that enables analysis of the complete genomic 
DNA sequence of a cell. This method provides the most comprehensive genotypic 
characterisation of microbes, including the identification of antimicrobial resistance 
determinants and virulence determinants (Thomas et al., 2017).  
The first step in many methods used for WGS is DNA fragmentation, where the DNA is 
enzymatically cut to small random fragments. The fragments are then amplified and 
sequenced.  After sequencing, computer software is used to piece the reads together to longer 
continuous stretches of sequences (contigs). The contigs are then joined together to form 
longer stretches of sequences (scaffolds) (Ekblom and Wolf, 2014). The assembled genome 
can then be uploaded to databases, such as the Rapid Annotation using Subsystem 
Technology server (RAST) (RAST, 2008), for annotation. In this process, the function of the 









Samples for this project included herring, mackerel, water and bivalve molluscs.  
Initial Sampling was conducted on a North Sea herring cruise which I attended from 29.05 to 
02.06 2018, on board the pelagic purse seine/trawler “MS Kings Bay”.  
Additional samples from herring and mackerel were obtained from research cruises which 
took place in September and November 2018.  
Bivalve molluscs were collected through the annual surveillance programme on Escherichia 
coli in bivalves, where samples are collected and sent to the institute by the Norwegian Food 
Safety Authority (NFSA). 
Locations for collection of water samples, sampling sites for bivalve molluscs, herring and 





                          Figure 2: The locations for collection of water samples, herring, mackerel and bivalve molluscs. 
 
2.1.1 Water samples 
 
Water samples were collected from four different locations (Figure 2) at five different depths 
from each location: surface, 2 m, 5 m, 7 m and 10 m respectively using a Van Dorn water 
sampler (KC Denmark, Denmark) collecting 3 l for each sample. The water temperature was 
recorded at each sampling site. 
From each sample, aliquots of 100 ml were collected in sterile plastic cups for pH and salinity 
measurements.  
For the detection of Vibrio spp., aliquots of 100-250 ml water were filtered through a filter 
with 0.45 µm pores (Merck Millipore, Germany) using the EZ-fit Manifold 3-place system 
(Merck Millipore, Germany) connected to a vacuum pump. The filters were transferred to 
Thiosulfate Citrate Bile Sucrose (TCBS) agar (Oxoid, UK) and incubated at 37 °C for 24-48 
hours. Five parallels were set up from each sample. For two of the parallels an enrichment 
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step was performed on approximately 500 ml water. For the enrichment step, the samples 
were added 50 mL concentrated (360 mg/ml) Alkaline Peptone Water (APW) (Oxoid, UK) 
and incubated at 42 °C for 18±2 hours. After incubation, 100 µl was streaked onto TCBS agar 
and incubated at 37 °C for 24-48 hours. The agar plates were stored at refrigerated 
temperature on board the ship. 
The TCBS plates were brought back to the laboratory at the IMR and stored at 4 °C.  At the 
lab, all plates were counted to estimate the number of colony forming units (cfu) per 100 ml. 
Single colonies were picked and sub cultured on to new TCBS plates at least three times to 




A total of 60 fish were sampled: 40 herring and 20 mackerel.  
At the last day of the research cruise in June 2018, 40 herring were collected from the storage 
tank on board the ship. Using gloves, the fish were picked by hand and placed in sterile plastic 
bags (WWR, USA). Two fish were placed in each plastic bag, comprising one sample. The 
herring was stored at chilled temperature and brought back to the lab at the IMR and stored at 
4 °C until further processing. 
From the herring, samples were collected from the muscle with skin, the intestine and the 
gills. Isolation of Vibrio spp. was based on the Nordic Committee on Food Analysis (NMKL) 
method no. 156 (NMKL, 1997). Using sterile scalpels, 20 g was cut from each tissue type and 
enriched in 180 ml APW with 2 % NaCl. Samples for detection of V. parahaemolyticus were 
enriched in APW with 2 % NaCl supplemented with polymyxin B (250 IU/ml). The 
enrichment cultures were incubated at 42±1 °C for18±2 hours. After incubation, a 10 µl loop 
of the enrichment culture was streaked on to TCBS plates and incubated at 37±1 °C for 24±3 
hours. From the TCBS plates, single colonies corresponding to Vibrio characteristics were 
picked and sub cultured on new TCBS plates at least three times to obtain pure cultures.  
From the mackerel cruise in September 2018, an additional 40 fish, comprising 20 samples, 
were obtained. Samples were collected from the muscle with skin and enriched in APW with 
and without polymyxin B. The enrichment cultures were incubated at 42±1 °C for18±2 hours. 
After the enrichment step, 10 µl from enrichment cultures were spread on TCBS agar and 
incubated at 37±1 °C for 24±3 hours. 
Samples were also collected from gut content and homogenized in phosphate buffered saline 
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(PBS) (Sigma-Aldrich, USA), and a ten-fold dilution series was made. The following 
dilutions were prepared: 10-1, 10-2 and 10-3. From each sample, 0.1 ml was transferred to 
TCBS agar and spread using an L-shaped spreader. Both undiluted and diluted samples were 
cultured on TCBS agar. The plates were incubated in 37±1 °C and read after 24- and 48 hours 
(NMKL, 1997). 
Samples were also collected from herring collected in November 2018. A total of 40 fish, 
comprising 20 samples, were brought to the lab and samples collected from the muscle with 
skin.  
 
2.1.3 Bivalve molluscs 
 
Analyses were based on  NMKL method no. 156 (NMKL, 1997). Samples comprised batches 
of 10-15 individual bivalve molluscs from 16 different locations, where 14 were blue mussels 
(Mytilus edulis), one flat oyster (Ostrea edulis), and one scallop (Pecten maximus).  
The bivalves were cleaned in cold water and opened using a sterile knife. From each sample 
approximately 100 g soft tissue and intra-valvular fluid was weighed in and homogenized 
using a stomacher for 2-3 min.  Aliquots of 20 g from each sample was transferred to new 
sterile bags and enrichment followed the same protocol as samples from fish.  
After incubation, 10 µl of the enrichment cultures were transferred to TCBS plates and to 
Vibrio ChromoSelect agar (VCS) (Sigma-Aldrich, USA) plates, and spread using a sterile 
loop. The plates were incubated at 37±1 °C for 24±3 hours. 
Before the enrichment step, approximately 1 ml of the homogenate was transferred to sterile 
tubes and the following dilutions were made using peptone water (bioMerièux, France): 10-1, 
10-2 and 10-3. From each dilution and the undiluted sample, 100 µl were transferred to TCBS 
plates and to VCS plates and spread using an L-shaped spreader. The plates were incubated 
37±1 °C for 48 hours and read after 24 and 48 hours. 
 
From both the TCBS plates and the VCS plates, single colonies corresponding to Vibrio 





2.2 Characterisation of the isolates 
 
Before characterisation of the isolates, they were re-streaked on to plate count agar (PCA) 
(Oxoid, UK) supplemented with 2 % NaCl. 
Characterisation was done by Gram testing, testing for the production of cytochrome c 
oxidase, light microscopy, Analytical Profile Index (API) 20 E (bioMèrieux, France), and by 
Matrix Assisted Laser Desorption Time Of Flight Mass spectrometry (MALDI-TOF MS). 
 
2.2.1 Gram test 
 
Gram-staining was performed on all isolates using the potassium hydroxide (KOH) method 
(Buck, 1982). This method depends on the lysis of Gram-negative cells in KOH releasing 
DNA from the cell to turn the suspension viscous. Colonies were transferred from the agar 
plates to a slide with a drop of 3 % KOH. The viscosity was determined by raising the loop 
from the slide. If a string was observed, the isolate was Gram-negative. If no string was 
observed, the isolate was Gram-positive. 
 
2.2.2 Oxidase test 
 
Oxidase testing was performed by dispensing a drop of remel Bactidrop 𝑇𝑀 oxidase (Thermo 
Fisher Scientific, USA) reagent on to a filter paper. Using a sterile loop, a colony was 
smeared on to the filter paper. Development of a violet colour within 10-30 sec. was 
interpreted as a positive reaction (Thermo Fisher Scientific, 2006). 
 
2.2.3 Cell morphology 
A drop of sterile water was transferred on to a slide before a colony was smeared on to the 
slide and the cell morphology of the isolates were studied by phase contrast microscopy with 
an Olympus BX40 microscope (Olympus optical, Japan) under the 1000x magnification using 





2.2.4 Analytical Profile Index 20E (API 20E)  
 
All isolates were preliminary identified using the API 20E test kit (bioMèrieux, France). A 
bacterial suspension corresponding to 0.5 McFarland standard was prepared by transferring 
well isolated, fresh colonies to 5 ml sterile saline (2 % NaCl). Using a sterile pipette, the 
bacterial suspension was transferred to the reaction wells on the API 20E strip. Depending on 
the substrate, the wells were filled with different volumes. For the following wells, both the 
well and couple were filled: CIT (citrate), VP (sodium pyruvate) and GEL (gelatine). For the 
remaining wells, only the lower part of the well was filled with the bacterial suspension. The 
wells containing arginine (ADH), lysine (LDC), ornithine (ODC), sodium thiosulfate (H2S) 
and urea (URE) were overlayed with mineral oil to create an anaerobic environment 
(bioMèrieux, 2002). The strip was placed in the tray filled with distilled water and a lid was 
placed over the tray to create a humid atmosphere. The API 20E strips were incubated at 
36±2 ˚C for 18-24 hours.  
After incubation, the strip was read according to the reading table provided by the 
manufacturer. The VP-well was added one drop of VP1 (bioMèrieux, France) and one drop of 
VP2 (bioMèrieux, France), the TDA well was added one drop of TDA reagent (bioMèrieux, 
France) and the IND well was added one drop of James reagent (bioMèrieux, France). A 
colour change in the VP well within 10 min. was interpreted as a positive reaction, while the 
TDA- and IND well was read immediately after addition of the reagents (bioMèrieux, 2002). 
Based on the results from the biochemical tests, each isolate was given a seven-digit number 
which was used to identify the isolates using the apiwebTM database. 
 
2.2.5 Matrix Assisted Laser Desorption Time Of Flight Mass Spectrometry (MALDI-TOF 
MS) 
 
All Gram-negative rod-shaped isolates and three Gram-positive isolates were cultured on 
PCA with 2 % NaCl, incubated at 37 ˚C over night and sent to the Norwegian Veterinary 
Institute (NVI) for identification by MALDI-TOF MS. The obtained Peptide Mass 
Fingerprints (PMFs) were compared to spectra in the commercial MALDI-TOF MS database 
(MALDI Biotyper, Bruker, Germany) and to spectra in an in-house generated database (NVI) 




2.3 Antimicrobial susceptibility testing 
2.3.1 Disk diffusion  
 
Antimicrobial susceptibility testing was conducted according to The Clinical and Laboratory 
Standards Institute (CLSI) method M42-A, Methods for Antimicrobial Disk Susceptibility 
Testing of Bacteria Isolated From Aquatic Animals (CLSI, 2006). 
The day before testing, the isolates were re streaked on to PCA supplemented with 2 % NaCl 
and incubated overnight in 28±2 °C or 22±2 °C, depending on the species to be tested. 
After incubation, fresh colonies were picked and suspended in 5 ml sterile saline (0.85 % 
NaCl) to the density of McFarland standard 0.5. A sterile cotton swab was dipped in the 
suspension and pressed against the inside of the tube to avoid over-inoculation. Using an 
automatic plate rotator, the inoculum was spread evenly with the cotton swab on plates with 
cation adjusted Mueller-Hinton agar (MHA) (Oxoid, UK).  
Each isolate was tested for their susceptibility against 18 antibiotics belonging to 10 different 
classes (Table 2) using antibiotic disks (Oxoid, UK). Six disks were placed on each plate, 
giving a total of three plates for each isolate. After application of the antibiotic disks, the 
MHA plates were stacked with five plates in each and incubated at 28±2 °C for 24-28 hours.  
To avoid erroneous reading of the inhibition zones, the 15-15-15 minute rule was applied: the 
inoculum suspension was used within 15 min. of preparation, the antibiotic disks were applied 
within 15 min. of inoculation of the MHA plates and the plates were incubated within 15 min. 
of disk application (EUCAST, 2017). E. coli CCUG17620 was used to assure the quality of 
the MHA plates and the antibiotic disks. 
V. aestuarianus has a lower optimum growth range (Tison and Seidler, 1983) then the rest of 
the isolated species, and for antimicrobial susceptibility testing of this species an incubation 
temperature of 22 °C was used. The inhibition zones were read after 24-28 hours and 44-48 
hours.  
After incubation, the inhibition zone for each antibiotic was measured using a digital calliper 
on the MHA plates flipped bottom-up and aligned against a dark background (Bauer et al., 
1966). To determine the isolates susceptibility against the antibacterial agents tested, the 
measured zone diameters were compared to breakpoints for Enterobacteriaceae from CLSI 
method M100, Performance Standards for Antimicrobial Susceptibility Testing 27th edition 
(CLSI, 2017). For the agents oxolinic acid, florfenicol and erythromycin, the measured zone 
42 
 
diameters were compared to breakpoints and epidemiological cut-off (ECOFF) values for 
Aeromonas salmonicida from CLSI method VET03/VET04-S2, Performance Standards for 
Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Second 
Informational Supplement (CLSI, 2014). Based on the breakpoints and ECOFF values, the 
isolates were classified as sensitive (S), intermediate (I) or resistant (R), or wildtype/non-
wildtype for each antibiotic tested. An inhibition zone equal to the disk diameter (6 mm) was 
regarded as no zone (Bauer et al., 1966).  
 
Table 2: The antibacterial agents used for antimicrobial susceptibility testing. All the agents tested are considered to have a 
broad spectrum of activity. 
Class Agent Concentration 
(µg) 
Penicillins Mecillinam (MEL) 10 
Ampicillin (AMP) 10 
Cephalosporins Cefotaxime (CTX) 5 
Ceftazidime (CAZ) 10 
Tetracyclines Doxycycline (DO) 30 
Tetracycline (TE) 30 
Quinolones Ciprofloxacin (CIP) 5 
Oxolinic acid (OA) 2 
Carbapenems Imipenem (IPM) 10 
Meropenem (MEM) 10 
Macrolides  Erythromycin (E) 15 






Trimethoprim (W) 5 
Aminoglycosides Gentamicin (CN) 10 
Tobramycin (TOB) 10 
Amphenicols Florfenicol (FFC) 30 
Monobactams Aztreonam (ATM) 30 
 
Five isolates from each species were selected for antimicrobial susceptibility testing on MHA 
supplemented with 1 % NaCl as recommended by CLSI for obligate halophilic strains (group 
2 organisms) (CLSI, 2006) to study differences in zone diameter with and without addition of 
NaCl to the medium. The diameter of inhibition zones was read after 24-28 hours of 
incubation at 28 °C. Isolates belonging to the species V. aestuarianus were incubated at 




2.3.2 Minimum Inhibitory Concentration (MIC) for imipenem 
 
As imipenem is one of the agents considered last line for treating multidrug resistant Gram- 
negative bacteria (Bier et al., 2015), isolates showing reduced susceptibility to this agent were 
selected for determination of Minimum Inhibitory Concentration (MIC) using M.I.C 
Evaluator Strips (Oxoid, UK). 
Fresh colonies were picked and suspended in sterile saline (0.85 % NaCl) to the density of 
McFarland standard 0.5.  A sterile cotton swab was dipped in the suspension and pressed 
against the inside of the tube to avoid over-inoculation. Using an automatic plate rotator, the 
inoculum was spread evenly on MHA plates with the cotton swab. The M.I.C evaluator strip 
was placed on the plate using sterile tweezers and the plates were incubated aerobically at 
28±2 °C for 24-28 hours. The MIC was read where the growth touched the strip. If the growth 
was inhibited between the sections on the strip, the MIC was read as the value in the white 
section above (Oxoid, 2008). The isolates tested were categorized as resistant, intermediate or 
susceptible to imipenem using breakpoints for Enterobacteriaceae from CLSI method M100 
(CLSI, 2017). 
E. coli CCUG17620 was included to assure the quality of the MHA and the M.I.C evaluator 
strips. 
 
2.3.3 CarbaNP (Carbapenemase Nordmann-Poirel) test 
 
Isolates showing reduced susceptibility to imipenem were examined for production of 
carbapenemase by the carbaNP test. The carba NP test is based on a reduction in pH due to 
the hydrolysis of carbapenems. The pH change will result in a colour change from red to 
yellow in a phenol red solution containing the carbapenem (Dortet et al., 2012). 
A phenol red solution was prepared by mixing 2 ml phenol red solution (Sigma-Aldrich, 
USA) (0.5 %) with 16.6 ml dH2O. The pH was adjusted to 7.8 with 1 M NaOH and 180 µl 10 
mM ZnSO4·7H2O were added to the solution. From each isolate, one 10 µl loop of colonies 
were transferred to 1.5 ml Eppendorf tubes containing 240 µl 5 M NaCl and vortexed for 
5 sec. The phenol red solution was added imipenem (Sigma-Aldrich, USA) to a final 
concentration of 6 mg/ml and vortexed. For each isolate, two 1.5 ml Eppendorf tubes were 
prepared, one tube containing phenol red solution with imipenem and one tube containing 
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only the phenol red solution as a negative control. Both tubes were inoculated with 100 µl of 
the bacterial solution and incubated at 37 °C. The results were read after 10, 20 and 30 min., 
and a colour change to yellow was interpreted as a positive reaction, while no colour change 
was interpreted as a negative result.  
OXA 48 and NDM1 were included as positive controls, and AmpC porin and TEM552 as 
negative controls. 
 
2.4 Determination of hemolytic activity 
 
Hemolytic activity of V. alginolyticus and V. metschnikovii on blood agar was determined on 
Tryptic Soy Agar (TSA) with 5 % sheep blood (VWR) or TSA with 5 % human blood.  
Blood agar plates containing human blood was prepared using TSA (Merck, Germany) as 
base. Blood was drawn from myself to EDTA tubes (BD Diagnostics, U.S.) by the help of an 
approved biomedical laboratory scientist. TSA was prepared by dissolving 40 g in 1000 ml 
distilled water. The pH was adjusted to 7.3±0.2, and the agar was autoclaved at 121 °C for 15 
min. The agar was chilled to 45-50 °C and 5 % blood was added under stirring. 
Approximately 12-15 ml agar was poured into sterile petri dishes. The plates were stored at 
4 °C until use. 
Isolates were streaked on to blood agar plates and incubated at 37 °C for 24 hours. Isolates 
showing a green zone around the colonies were classified as α-hemolytic, while isolates 
showing a clear zone around the colonies were classified as β-hemolytic (Engelkirk et al., 
2011). 
 
2.5 Molecular methods 
2.5.1 Extraction of DNA 
 
Bacterial cells were harvested by transferring 3-4 10 µl loops of colonies to 1.5 ml Eppendorf 
tubes containing 500 ml PBS. The tubes were centrifuged at 16860 rcf for 1 min. before the 
supernatant was removed. The pellet was dissolved in 300 ml PBS and centrifuged at 16860 
rcf for 1 min. The supernatant was removed, and the pellet was resuspended in 500 ml sterile 
water. Working solutions were prepared by transferring 200 µl of the bacterial suspension to 
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new 1.5 ml Eppendorf tubes, and centrifuging the tubes at 16990 rcf for 1 min. The 
supernatant was removed, and the pellets were stored at -20 ° until use.  
Extraction of DNA from bacterial isolates was done using the DNeasy Blood & Tissue kit 
(Qiagen, Germany). An additional lysis step was performed by resuspending the samples in 
180 µl lysis buffer and incubating them at 37 °C over night. The samples were then 
completely lysed by adding 25 µl proteinase K and 200 µl AL buffer to the samples. The 
samples were then incubated at 56 °C for 30 min. After incubation, 200 µl 96 % ethanol was 
added to each sample, before the solution was transferred to the DNeasy spin column. The 
column was centrifuged at 5900 rcf for 1 min. before the flow-through was discarded. The 
column was transferred to a new collection tube and added 500 µl AW1 buffer and 
centrifuged at 5900 rcf for 1 min. After centrifugation, the spin column was placed in a new 
collection tube and added 500 µl buffer AW2. The spin column was then centrifuged at 16100 
rcf for 3 min. The flow-through was discarded and the column placed in a 1.5 ml Eppendorf 
tube. To elute DNA from the column, 50 µl AE buffer was pipetted directly on to the DNeasy 
membrane before the tubes were centrifuged at 5900 rcf for 1 min. The elution was repeated 
by transferring the spin column to a new 1.5 ml Eppendorf tube and adding 30 µl buffer AE 
on to the membrane (Quiagen, 2006).The tubes were then centrifuged at 5900 rcf for 1 min. 
The purity (260/280 and 260/230 ratios) and concentration of the elute was measured using 
Nanodrop ND-1000 (NanoDrop Technologies, USA). The DNA concentrations were also 
measured using Qubit 2.0 (Invitrogen, USA). The DNA elute was stored at -20 °C.  
 
2.5.2 Taxonomy sequencing 
 
Isolates characterised as Gram-negative, oxidase positive, able to grow well on PCA with 2 % 
NaCl and not identified by MALDI-TOF MS were subjected to rpoB sequencing. 
A PCR mix was prepared by mixing 5 µl 10x HiFi buffer, 2 µl MgSO4 (50 mM), 1 µl dNTP 
mix, 0.5 µl primer 1110-F (5`-GTAGAATCTACCGCATGATG-3`), 0.5 µl primer CM32b-R 
(5`-CGGAACGGCCTGACGTTGCAT-3`), 0.2 µl Platinum® Taq HiFidelity polymerase and 
approximately 100 ng of the template in a 200 µl PCR tube. The final volume was adjusted to 
50 µl with nuclease free H2O. The PCR tubes were placed in a GeneAmp PCR system 9700 
(Applied Biosystems, USA), and the following programme was used; 94 °C for 5 min., then 
35 cycles of 94 °C for 30 sec. and 68 °C for 30 sec, followed by 72 °C for 30 sec. A final step 
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on 72 °C for 7 min. and a hold on 4 °C ended the program.  The PCR products were checked 
by gel electrophoresis (1 % agarose gel stained with Gel Red Nucleic Acid Stain (Biotium, 
USA)) and UV illumination.  
 
The resulting 984 bp PCR products were purified using the QIAquick PCR purification kit 
(Qiagen, Germany). For sequencing of the products, the PCR primers and additional 
sequencing primers were used: 1661-F (5`-TTYATGGAYCARAACAACCC-3`) and 1783-R 
(5`-GGACCTTYAGGNGTTTCGAT-3`). The following reaction was prepared in 200 µl 
PCR tubes, four tubes per sample: 1 µl Big Dye®, 1 µl sequencing buffer, 5-20 ng template, 
and 0.5 µl primer, one primer per PCR tube.  The total volume was adjusted to 10 µl with 
MilliQ H2O. A PCR was run with the following programme: 96 °C for 5 min, then 25 cycles 
of denaturation at 96 °C for 10 sec., primer hybridization at 50 °C for 5 sec. and elongation at 
60 °C for 4 min. The reaction was ended with at hold at 4 °C. 
The PCR products were sent to The sequencing facility at the University of Bergen (UoB) for 
sequencing. The obtained rpoB sequences were analysed using the BLAST tool and compared 
to sequences in the Nucleotide collection (nr/nt) database. 
To assure that isolates intended for Whole Genome Sequencing (WGS) were in pure cultures, 
a total of 23 isolates were subjected to 16s rRNA sequencing. 
The PCR reaction was prepared as described for rpoB sequencing with the exception of the 
primers used and the PCR program.  For 16s rRNA, the primers BA338-F (5′ACT CCT ACG 
GGA GGC AGC AG 3′) and UN518-R (5′ATT ACC GCG GCT GCT GG 3′) were used. The 
following program was used: 94 °C for 2 min., then 30 cycles of 94 °C for 30 sec. and 54 °C 
for 30 sec, followed by 68 °C for 1 min. A final step on 68 °C for 7 min. and a hold on 4 °C 
ended the program.  The resulting approximately 200 bp PCR products were purified using 
the QIAquick PCR purification kit. For sequencing of the products, only primer BA338-F was 
used. The PCR mix and program followed the same protocol as for rpoB sequencing.  
 
The PCR products were sent to The sequencing facility at the UoB for sequencing. 
The finished 16s rRNA sequences were analysed using the BLAST tool and compared to 




2.5.3 Whole Genome Sequencing (WGS) 
 
A selection of 23 isolates, eight V. anguillarum, six V. metschnikovii, seven V. alginolyticus 
and two V. cincinnatiensis, were sent to the Norwegian Sequencing Centre (NSC) for WGS. 
Before the samples were sent to the NSC, they were run on a 0.8 % agarose gel to examine if 
the DNA was degraded.  
 
The obtained raw sequence data was processed at the IMR by using BBDuk to remove the 
adaptor sequences from the reads and to trim low-quality ends. The genomes were assembled 
from the reads using SPAdes and uploaded to the Rapid Annotation using Subsystem 
Technology server (RAST) (RAST, 2008) for annotation. The assembled genomes were also 
uploaded to the Virulence Factors Database (VFDB) (VFDB, 2018) for detection of virulence 
factors and to the Comprehensive Antibiotic Resistance Database (CARD) (CARD, 2019) for 







3.1 Locations, samples and amount of bacteria 
 
A total of 20 water samples were collected and depth (m), temperature (°C) and salinity (‰) 
were registered, prior to analysis of cfu/100 ml on TCBS agar.  
The highest temperatures were measured at the location closest to shore (Location 1), in 
Sample 1 (surface), 16 °C, and Sample 2 (2 m), 15 °C. From all other sampling locations 
temperatures ≤ 15 °C were measured (Figure 3). 
 
 
Figure 3: Measured temperature (°C) in each sample from each location. Note: different values on y-axis on each graph. 
 
The lowest salinity was measured in the samples collected closest to shore (Location 1) in the 
surface and at 2 m depth, while it increased with increasing depth at this location. The highest 




Figure 4: Measured salinity (‰) in each sample from each location. Note: different values on both axis on each graph. 
 
The highest number of cfu/100 ml was found in Sample 1 (surface) and 2 (2 m) from the 
sampling location closest to shore (Location 1). From the samples collected further from 
shore and at lower depths, a lower cfu/100 ml was counted (Figure 5).  The highest number of 
cfu/100 ml was found were the water temperature was ≥ 15 °C and salinity ≤ 17 ‰. 
 
  
Figure 5: Number of colony forming units (cfu)/100 ml water on TCBS plates incubated at 37 °C for 24-48 hours counted in 




In addition to the water samples, 60 fish samples and 16 bivalve molluscs were collected and 
analysed.  
 
3.2 Characterisation of the isolates  
 
From the samples, a total of 177 colonies were picked from TCBS- and VCS plates and 
isolated in pure cultures for further analysis. Of these, a total of 83 of these were isolated from 
water samples, 70 from fish samples and 24 from bivalve molluscs. From the water samples, 
88 % of the colonies were isolated from Location 1, 7 % from Location 2 and 5 % from 
Location 3. From the fish samples, 41 % of the colonies were picked from samples from 
muscle with skin (n=60), 31 % from intestine (n=40) and 27 % from gills (n=20). From the 
bivalves, 67 % of the isolates came from Sample 4. 
A first characterisation of the total 177 isolates was done by Gram testing, oxidase testing, 
microscopy and identification by API 20E.  A total of 174 were Gram-negative, rod-shaped 
bacteria, while three were identified as Gram-positive cocci. Based on the results from the 
oxidase test, 102 of the Gram-negative isolates were found to be oxidase positive and 72 were 
oxidase negative. Among the 177 isolates, 65 were identified as Vibrio spp. using the API 
20E system, while the remaining isolates were identified as other species or yielded an 
unacceptable profile. Several of the obtained profiles gave low identification scores and T 
values (Table 3).  
Table 3: Isolated colonies identified by API 20E. Excellent identification: %ID≥99.9, T≥0.75, Very good identification: 
%ID≥99.0, T≥0.50, Good identification: %ID≥90.0, T≥0.25, Acceptable identification: %ID≥80.0, T≥0. 
A. hydrophila/caviae/sobria: Aeromonas hydrophila/caviae/sobria, P. pneumotropica /M. haemolytica: 
Pasteurella pneumotropica/Mannheimia haemolytica, S. putrefaciens: Shewanella putrefaciens, P.damsela: Photobacterium 
damsela, P. vulgaris: Proteus vulgaris. 
No. of isolates Bacterium 
 
%ID – range T value - range 
54 V. alginolyticus 85.9 - 99.3 % 0.66 - 0.81 
8 V. cholerae 89.8 - 98.5 % 0.41 - 0.71 
2 V. fluvialis 56.5 - 93.5 % 0.51 - 0.52 
1 Vibrio sp.  49.7 % 0.53 
49 A. hydrophila/caviae/sobria 1/2  37.3 - 98.8 % 0.28 - 0.84 
28 P. pneumotropica/M. haemolytica  34.4 - 99.2 % 0.42 - 0.69 
5 S. putrefaciens >99 % 0.42 - 0.9 
1 P. damsela 88 % 0.11 
2 P. vulgaris 99.2 - 99.9 % 0.93 





All 177 isolates were sent for identification by MALDI-TOF MS. The results from MALDI-
TOF MS identified 133 of the isolates as Vibrio spp., eight were species within the genus 
Proteus, four isolates were identified as Shewanella putrefaciens and three isolates were 
identified as Staphylococcus spp. Four Vibrio species were identified using MALDI-TOF MS, 
including 64 V. alginolyticus, 38 V. metschnikovii, 24 V. anguillarum and seven 
V. aestuarianus. Two of the 64 V. alginolyticus had a score value < 2.0, placing them in 
category B (Low-confidence identification), while the remaining 62 isolates had a score >2.0, 
placing them in category A (High-confidence identification). All the isolated V. metschnikovii 
strains were given a score value between 1.70 – 1.90, placing them in category B, while all 
the V. anguillarum and V. aestuarianus strains had score values > 2.0.  A total of 29 isolates 
failed to be identified by the MALDI-TOF MS. 
Comparing the results from the API 20E system and MALDI-TOF MS, 83 % of the 
V. alginolyticus strains were identified to the same species using both methods, while 11 % 
were identified as other Vibrio spp. using the API 20E system. None of the 38 V. 
metschnikovii were identified correctly by API 20E, but 11 % were identified as members of 
the genus Vibrio. None of the isolated V. anguillarum and V. aestuarianus were identified to 
the correct species by API 20E, while 14 % of the V. aestuarianus strains were identified as 
other Vibrio spp. 
 
3.3 rpoB sequencing 
Two of the isolates not identified by MALDI-TOF MS were characterised as Gram-negative, 
oxidase positive and halophilic isolates, and were subjected to rpoB sequencing for 
identification. The rpoB sequences were analysed using the BLAST tool and compared to 
sequences in the Nucleotide collection (nr/nt) database. Both isolates were identified as 





3.4 Prevalence of Vibrio spp. 
 
Based on the results from identification by MALDI-TOF MS and rpoB sequencing, 
Vibrio spp. was detected in 45 % of the water samples (n=20), 43 % of fish samples (n=60) 
and in 31 % of the samples from bivalve molluscs (n=16). Only 11 % of the vibrios isolated 
from the water samples were recovered from enrichment cultures, the remaining were isolated 
from cultivation of filters without an enrichment step. From fish, Vibrio spp. was isolated 
from 40 % of samples from gills, 20 % of samples from the intestine and 32 % in samples 
from skin and flesh. A total of 87.5 % of Vibrio spp. from bivalve molluscs were isolated by 
direct plating of undiluted samples, while the remaining isolates from bivalve molluscs were 
recovered from enrichment cultures. 
From the water samples, V. alginolyticus was the most frequently isolates species followed by 
V. aestuarianus, V. metschnikovii, V. anguillarum and V. cincinnatiensis (Table 4). 
V. metschnikovii was the most frequently detected species in fish, with 85 % of all 
V. metschnikovii isolated from fish. The only other Vibrio sp. isolated from fish was 
V. alginolyticus (Table 4).  Both V. anguillarum and V. alginolyticus were isolated from 
bivalve molluscs. Totally 87.5 % of the isolated V. anguillarum were recovered from bivalve 
molluscs, while 5 % of the isolated V. alginolyticus were detected from the same samples 
(Table 4). 
 
             Table 4: Vibrio spp. isolated from water samples, fish and bivalve molluscs.  











V. alginolyticus 57 4 0 0 3 
V. metschnikovii 6 15 9 8 0 
V. anguillarum 3 0 0 0 21 
V. aestuarianus 7 0 0 0 0 
V. cincinnatiensis* 2 0 0 0 0 
         *: uncertain identification. 
 
3.5 Antimicrobial susceptibility testing 
 
3.5.1 Disk diffusion 
 
The antimicrobial susceptibility of all isolated Vibrio spp. was tested against 18 antimicrobial 
agents belonging to 10 classes according to CLSI method M42-A. An additional six 
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V. metschnikovii isolated from Atlantic mackerel at the IMR during the spring of 2017 were 
included in the antimicrobial susceptibility testing. 
Resistance to ampicillin was observed in all examined V. alginolyticus (n=64), V. anguillarum 
(n=24), in 27.3 % of the isolated V. metschnikovii (n=44) and in 28.6 % of examined 
V. aestuarianus (n=7). A total of 12 isolates were susceptible to all antibiotics tested, all 
identified as V. metschnikovii. All isolates, regardless of species, were susceptible to 
tetracycline, doxycycline, meropenem, mecillinam, florfenicol, ciprofloxacin, azithromycin 
and sulfamethoxazole/trimethoprim.  
 
All V. anguillarum isolates tested showed phenotypic resistance to ampicillin and were 
resistant or intermediate susceptible to imipenem. Two isolates were resistant to aztreonam, 
while 14 isolates showed intermediate susceptibility for this agent. Seven of the tested isolates 
were categorized as resistant to erythromycin. Resistance to ampicillin, imipenem and 
aztreonam was observed in two isolates (Figure 6).   
 
  
Figure 6: Antimicrobial resistance patterns among V. anguillarum (n=24). AMP: Ampicillin, MEL: Mecillinam, CTX: 
Cefotaxime, CAZ: Ceftazidime, TE: Tetracycline, DO: Doxycycline, CIP: Ciprofloxacin, OA: Oxolinic acid, IPM: Imipenem, 
MEM: Meropenem, E: Erythromycin, AZM: Azithromycin, SXT: Sulfamethoxazole/Trimethoprim, W: Trimethoprim, TOB: 
Tobramycin, CN: Gentamicin, FFC: Florfenicol, ATM: Aztreonam, AMP+IPM+ATM: Sum of susceptible, intermediate 
susceptible or resistant isolates to the individual agents AMP, IPM and ATM. S: Susceptible, I: intermediate, R: Resistant. 
 
Among the V. metschnikovii isolates, 12 were resistant to ampicillin, 11 were resistant to 
tobramycin and 12 intermediate susceptible to this antibiotic, 12 showed intermediate 
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susceptibility to gentamicin, four isolates were intermediate susceptible to ceftazidime and 
three isolates showed intermediate susceptibility to cefotaxime. Two V. metschnikovii isolates 
were intermediate susceptible to aztreonam and one of the tested strains were intermediate 
susceptible to oxolinic acid (Figure 7). Two of the isolates tested were resistant against 
ampicillin and tobramycin, and intermediate susceptible against cefotaxime, ceftazidime, 
gentamicin and aztreonam.  
 
 
Figure 7: Antimicrobial resistance patterns among V. metschnikovii (n=44). AMP: Ampicillin, MEL: Mecillinam, CTX: 
Cefotaxime, CAZ: Ceftazidime, TE: Tetracycline, DO: Doxycycline, CIP: Ciprofloxacin, OA: Oxolinic acid, IPM: Imipenem, 
MEM: Meropenem, E: Erythromycin, AZM: Azithromycin, SXT: Sulfamethoxazole/Trimethoprim, W: Trimethoprim, TOB: 
Tobramycin, CN: Gentamicin, FFC: Florfenicol, ATM: Aztreonam, AMP+TOB: Sum of susceptible, intermediate susceptible 
or resistant isolates to individual the individual agents AMP and TOB, AMP+TOB+CN: Sum of susceptible, intermediate 
susceptible or resistant isolates to the individual agents AMP, TOB and CN. S: Susceptible, I: intermediate, R: Resistant. 
 
All V. alginolyticus isolates showed resistance against ampicillin. Three of the tested isolates 
were resistant to oxolinic acid, while 41 showed intermediate susceptibility to this agent. 
Three isolates did not grow on MHA and were therefore tested on MHA supplemented with 
1 % NaCl. Two of the tested isolates were intermediate susceptible to trimethoprim and two 
showed intermediate susceptibility against aztreonam. The two isolates showing reduced 




Figure 8: Antimicrobial resistance patterns among V. alginolyticus (n=64). AMP: Ampicillin, MEL: Mecillinam, CTX: 
Cefotaxime, CAZ: Ceftazidime, TE: Tetracycline, DO: Doxycycline, CIP: Ciprofloxacin, OA: Oxolinic acid, IPM: Imipenem, 
MEM: Meropenem, E: Erythromycin, AZM: Azithromycin, SXT: Sulfamethoxazole/Trimethoprim, W: Trimethoprim, TOB: 
Tobramycin, CN: Gentamicin, FFC: Florfenicol, ATM: Aztreonam. S: Susceptible, I: intermediate, R: Resistant. 
 
Resistance against aztreonam was observed in all V. aestuarianus isolates. Two of the isolates 




Figure 9: Antimicrobial resistance patterns among V. aestuarianus (n=7). AMP: Ampicillin, MEL: Mecillinam, CTX: 
Cefotaxime, CAZ: Ceftazidime, TE: Tetracycline, DO: Doxycycline, CIP: Ciprofloxacin, OA: Oxolinic acid, IPM: Imipenem, 
MEM: Meropenem, E: Erythromycin, AZM: Azithromycin, SXT: Sulfamethoxazole/Trimethoprim, W: Trimethoprim, TOB: 
Tobramycin, CN: Gentamicin, FFC: Florfenicol, ATM: Aztreonam, AMP+ATM: Sum of susceptible, intermediate susceptible 





Since most Vibrio spp.  have higher salt requirements than the approximately 0.86 % NaCl 
found in MHA, a selection of five isolates from each of the identified Vibrio spp. were 
subjected to antimicrobial susceptibility testing by the same disk diffusion method only on 
MHA supplemented with 1 % NaCl. Of the five V. anguillarum isolates tested on MHA 
supplemented with 1 % NaCl, one of the isolates changed from susceptible to resistant for 
cefotaxime, and from susceptible to intermediate for ceftazidime. Two of the isolates changed 
from susceptible to intermediate susceptible for cefotaxime, while one isolate previously 
susceptible to ceftazidime were classified as intermediate. A reduction in zone diameter for 
aztreonam was observed for all the tested isolates, classifying three isolates previously 
susceptible as resistant when tested on media containing 1 % NaCl. A reduced mean 
inhibition zone was measured for all agents, with the exception of trimethoprim (Figure 10). 
  
Figure 10: Mean zone diameter (mm) around antibiotic disks for V. anguillarum (n=5) when tested on Mueller Hinton agar 
(MHA) and MHA supplemented with 1 % NaCl (MHA W/ 1 % NaCl).  AMP: Ampicillin, MEL: Mecillinam, CTX: 
Cefotaxime, CAZ: Ceftazidime, TE: Tetracycline, DO: Doxycycline, CIP: Ciprofloxacin, OA: Oxolinic acid, IPM: Imipenem, 
MEM: Meropenem, E: Erythromycin, AZM: Azithromycin, SXT: Sulfamethoxazole/Trimethoprim, W: Trimethoprim, TOB: 
Tobramycin, CN: Gentamicin, FFC: Florfenicol, ATM: Aztreonam 
 
When tested on MHA with 1 % NaCl, one V. metschnikovii isolate previously susceptible to 
ceftazidime became resistant, while three previously intermediate susceptible changed to 
resistant to this agent. One isolate showed intermediate susceptibility to ceftazidime on MHA, 
but when tested on MHA w/ 1 % NaCl, it was classified as susceptible. A change in 
susceptibility was also observed for the aminoglycosides. Three isolates changed from 
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resistant to intermediate susceptible to tobramycin, one from intermediate susceptible to 
susceptible and one isolate went from intermediate to resistant. Three V. metschnikovii 
isolates were classified as intermediate susceptible to gentamicin on MHA, and sensitive on 
MHA w/ 1 % NaCl. Four of the tested isolates were resistant to aztreonam when tested on 
MHA w/ 1 % NaCl, of these, three were sensitive and one was intermediate susceptible on 
MHA. One V. metschnikovii changed from intermediate susceptible to susceptible to 
aztreonam. However, a reduced mean inhibition zone was observed for all agents, except for 
the aminoglycosides and sulfamethoxazole/trimethoprim, where similar or increased zones 
were seen (Figure 11). 
 
Figure 11: Mean zone diameter (mm) around antibiotic disks for V. metschnikovii (n=5) when tested on Mueller Hinton agar 
(MHA) and MHA supplemented with 1 % NaCl (MHA W/ 1 % NaCl).  AMP: Ampicillin, MEL: Mecillinam, CTX: 
Cefotaxime, CAZ: Ceftazidime, TE: Tetracycline, DO: Doxycycline, CIP: Ciprofloxacin, OA: Oxolinic acid, IPM: Imipenem, 
MEM: Meropenem, E: Erythromycin, AZM: Azithromycin, SXT: Sulfamethoxazole/Trimethoprim, W: Trimethoprim, TOB: 
Tobramycin, CN: Gentamicin, FFC: Florfenicol, ATM: Aztreonam 
 
Antimicrobial resistance among the tested V. alginolyticus was observed for only a few 
antimicrobial agents. When tested on media containing 1 % NaCl, one isolate was 
intermediate susceptible to cefotaxime. Two isolates became intermediate susceptible to 
trimethoprim and tobramycin. Two isolates changed from intermediate susceptible to resistant 
to oxolinic acid and two isolates from sensitive to intermediate susceptible to the same agent. 
One of the tested strains categorized as wild-type to erythromycin on MHA became non-wild-
type when tested on media supplemented with NaCl, while one of the isolates previously 
sensitive to aztreonam, was categorized as intermediate susceptible to this agent on MHA 
58 
 
with 1 % NaCl. All the tested isolates showed smaller inhibition zones to all agents when 
tested on media supplemented with NaCl (Figure 12).  
 
Figure 12: Mean zone diameter (mm) around antibiotic disks for V. alginolyticus (n=5) when tested on Mueller Hinton agar 
(MHA) and MHA supplemented with 1 % NaCl (MHA W/ 1 % NaCl).  AMP: Ampicillin, MEL: Mecillinam, CTX: 
Cefotaxime, CAZ: Ceftazidime, TE: Tetracycline, DO: Doxycycline, CIP: Ciprofloxacin, OA: Oxolinic acid, IPM: Imipenem, 
MEM: Meropenem, E: Erythromycin, AZM: Azithromycin, SXT: Sulfamethoxazole/Trimethoprim, W: Trimethoprim, TOB: 
Tobramycin, CN: Gentamicin, FFC: Florfenicol, ATM: Aztreonam 
 
Among the tested V. aestuarianus, a change in susceptibility pattern for ceftazidime was 
observed for two isolates. One of the isolates changed from susceptible to resistant, and one 
isolate from susceptible to intermediate susceptible for this agent. An increased inhibition 
zone was measured for ampicillin, while a reduced or similar inhibition zone was measured 





Figure 13: Mean zone diameter (mm) around antibiotic disks for V. aestuarianus (n=5) when tested on Mueller Hinton agar 
(MHA) and MHA supplemented with 1 % NaCl (MHA W/ 1 % NaCl).  AMP: Ampicillin, MEL: Mecillinam, CTX: 
Cefotaxime, CAZ: Ceftazidime, TE: Tetracycline, DO: Doxycycline, CIP: Ciprofloxacin, OA: Oxolinic acid, IPM: Imipenem, 
MEM: Meropenem, E: Erythromycin, AZM: Azithromycin, SXT: Sulfamethoxazole/Trimethoprim, W: Trimethoprim, TOB: 
Tobramycin, CN: Gentamicin, FFC: Florfenicol, ATM: Aztreonam 
 
3.5.2 MIC for imipenem  
 
All 24 V. anguillarum isolates showed resistance to, or reduced susceptibility to imipenem. A 
MIC test was performed on these isolates and showed that MIC values ranged from 2 µg/ml 
to 8 µg/ml, classifying them as either resistant or intermediate susceptible to imipenem. A 
total of 21 isolates were classified as resistant, while the remaining three isolates were 
classified as intermediate susceptible. 
 
3.5.3 CarbaNP test 
 
All V. anguillarum isolates showing reduced susceptibility or resistance against imipenem 
was examined for production of carbapenemase by the carbaNP test.  No positive reaction 




3.6 Determination of hemolytic activity 
 
All isolated V. alginolyticus (n=64) and V. metschnikovii (n=44) were screened for hemolytic 
activity on TSA with 5 % sheep blood and TSA with 5 % human blood.  None of the V. 
alginolyticus showed hemolytic activity on neither TSA with sheep – or human blood. For V. 
metschnikovii, α hemolysis was observed for all isolates on TSA with 5 % human blood. 
When grown on TSA with 5 % sheep blood, 39 of the V. metschnikovii isolates were α 
hemolytic, while five isolates were β hemolytic (Table 5).   
  
Table 5: Results from determination of hemolytic activity in V. metschnikovii and V. alginolyticus. TSA: Tryptic Soy Agar, 
α: alpha hemolysis, β: beta hemolysis. 
  TSA w/ 5% sheep blood TSA w/ 5% human blood 
Bacterium α β α β 
V. alginolyticus (n=64) 0 0 0 0 
V. metschnikovii (n=44) 39 5 44 0 
 
 
3.7 Whole genome sequencing 
 
A total of eight V. anguillarum, seven V. alginolyticus, six V. metschnikovii and one 
V. cincinnatiensis were whole genome sequenced. The assembled genomes were annotated in 
RAST and uploaded to the VFDB- and CARD database. Genes encoding a thermolabile 
hemolysin (TLH) and hemolysin A (HlyA) was detected in all examined V. metschnikovii, 
and one of these isolates had an additional hemolysin and genes encoding repeat-in-toxin 
(RTX) was detected. All V. alginolyticus were positive for a tlh associated gene. Among V. 
anguillarum, TLH, HlyA and RTX was detected in all but one strain (Table 6). 
  
Table 6: Known virulence factors detected using VFDB and RAST. HlyA: Hemolysin A, TLH: Thermolabile hemolysin, RTX: 
Repeat-in-Toxin 
Species Hemolysins Toxins 
V. alginolyticus (n=7) - TLH (100%) - - 
V. metschnikovii (n=6) HlyA (100%) TLH (100%) Hemolysin III (17%) RTX (17%) 
V. anguillarum (n=8) HlyA (87%) TLH (87%) - RTX (87%) 
V. cincinnatiensis * (n=1)  -  -  -  - 




Several resistance determinants were detected in the isolates subjected to WGS (Table 7). 
A class A CARB β-lactamase gene was detected in all V. alginolyticus and all but one 
V. metschnikovii. In V. alginolyticus and one V. anguillarum a putative class C β-lactamase 
gene was found. Most of the examined V. alginolyticus also had an additional putative 
subclass B3 β-lactamase gene and in one of the V. anguillarum strains a putative V. cholerae 
varG gene encoding a class B β-lactamase was detected. In all V. alginolyticus both a 
quinolone resistance B protein (QnrB) and parE conferring resistance to quinolones were 
detected. Resistance-Nodulation cell Division (RND) efflux pumps were detected in all 
examined isolates. 
 
Table 7: Resistance determinants detected in vibrio isolates subjected to whole genome sequencing using the RAST server 
and CARD database. CARB: Carbenicillin-hydrolysing, RND: Resistance-Nodulation Cell Division. QnrB: Quinolone 
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4. Discussion  
4.1 Identification of Vibrio spp. 
 
Identification and differentiation of Vibrio spp. can be difficult. During this project, a first 
characterisation of the isolates was conducted by Gram testing, oxidase testing and 
microscopy. Further identification was done using API 20 E, MALDI-TOF MS and rpoB 
sequencing. 
The API 20E system identified 68 of the 177 isolates as members of the genus Vibrio, 
whereas examination by MALDI-TOF MS increased the number of identified Vibrio isolates 
to 133. Comparing the results of the two methods, 84 % of V. alginolyticus were identified to 
the correct species. None of the other species were identified correctly using API 20E. This is 
likely because the API 20E database only contain six Vibrio species: V. alginolyticus, 
V. cholerae, V. fluvialis, V. mimicus, V. parahaemolyticus and V. vulnificus (bioMèrieux, 
2015), and not the other four Vibrio spp. that were identified by MALDI-TOF MS. The API 
system is primarily designed for clinical application (Viña-Feas et al., 2006) and therefore not 
ideal for identification of environmental vibrios. A total of 16 % of the isolated 
V. alginolyticus were not identified correctly using API 20E. When this test was done, an 
inoculum with 2 % NaCl was used. The concentration of NaCl can affect the biochemical 
profile and lead to erroneous identification with this system (Tarr et al., 2007). Other factors 
which can lead to misreading of the results is the formation of air bubbles in the anaerobic 
wells, and thereby cause false positive results, or misinterpretation of weak positive or 
negative reactions. Some of the isolated V. metschnikovii were attempted identified using the 
KB007 HiVibrio Identification Kit (HiMedia, India), but the few tested isolates were not 
identified to the correct species and no further work was done with this system.  
 
All the isolated Vibrio spp. were oxidase positive with the exception of V. metschnikovii, 
which together with V. gazogenes is the only known Vibrio spp. lacking cytochrome c oxidase 
(Farmer et al., 1988). This feature may cause this species to be overlooked when analysing 
raw fish and shellfish, and samples from the environment, as most Vibrio spp. are oxidase 
positive (Matté et al., 2007;NMKL, 1997). 
MALDI-TOF MS proved to be a valuable method for the identification of Vibrio spp. A total 
of 133 isolates were identified as Vibrio spp. All the identified vibrios, except the isolated 
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V. metschnikovii and two V. alginolyticus, were placed in category A (High-confidence 
identification). However, this method was not able to identify 29 of the isolates. Of these, two 
were oxidase positive and able to grow well on PCA with 2 % NaCl, hence categorized as 
slight halophilic bacteria. These two isolates were selected for identification by sequencing of 
the rpoB gene. A method which has been shown valuable in the identification of and 
differentiation of Vibrio spp. The obtained sequences were analysed using the BLAST tool, 
and identified as V. cincinnatiensis, but with a low score. The BLAST database only contains 
two rpoB sequences from this species, and this may explain the relatively low score.  
However, these isolates were subjected to WGS, but one failed the library preparation. From 
the assembled genome, the 16s rRNA and other rpo- sequences were extracted and analysed 
using BLAST. All these genes gave different identification, and as a consequence the 
identification of this isolate remains unclear. These isolates are referred to as 
V. cincinnatiensis throughout this thesis. This illustrates the difficulties in identifying Vibrio 
spp., and shows that the available identification tools for vibrios are suboptimal and may yield 
conflicting results. 
 
4.2 Prevalence of Vibrio spp. in the Norwegian marine environment  
 
During the study period, a total of 20 water samples, 60 fish samples and 16 samples from 
bivalve molluscs were examined for the presence of potentially pathogenic Vibrio spp. A total 
of 135 vibrios were isolated from these samples using a method based on NMKL no. 156. 
Among the species considered to be human pathogenic, V. alginolyticus was isolated from all 
sources, while V. metschnikovii was isolated from fish- and water samples. Two 
V. cincinnatiensis were isolated from water samples. Of the non-human pathogenic vibrios, 
V. anguillarum was isolated from both bivalves and water samples, whereas V. aestuarianus 
was only isolated from water samples. However, both V. anguillarum and V. aestuarianus can 
cause disease in marine animals and are known to cause problems in the aquaculture industry 
(Travers et al., 2017;Roux et al., 2015;Chatterjee S, 2012) 
From the water samples, the highest number of Vibrio isolates were recovered from the first 
sampling location, closest to shore and were the measured temperature was the highest. A 
total of 69 % of the isolated V. alginolyticus were isolated from the samples collected closest 
to shore at surface and 2 m depth, were the temperature was measured to ≥15 °C and the 
salinity to ≤25 ‰, which are the preferred conditions for the vibrios (Vezzulli et al., 
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2013;Vezzulli et al., 2015). Totally, 50 % of all Vibrio spp. isolated from water were 
recovered from the first sampling location. V. alginolyticus is usually the dominating species 
in Vibrio communities (Fu et al., 2016), as seems to be in accordance with the results from 
this study. 
Only seven Vibrio isolates were from enrichment cultures from the water samples, one 
V. metschnikovii and six V. alginolyticus, possibly indicating a sub-optimal enrichment 
method for the water samples. As APW is not specific for Vibrio spp., other bacteria present 
in the samples may overgrow the vibrios (Huq et al., 2012). Previous studies have indicated 
better success when isolating V. cholerae from seawater by filtering of the samples before 
enrichment, and enrichment of bacteria on the filter (Ellingsen, 2008). After cultivation of the 
filters on TCBS plates, the plates were stored at 4 °C for approximately two weeks before 
further analysis. If the TCBS plates are not examined immediately after incubation, sucrose 
positive colonies may revert to green. This may have caused problems as almost all colonies 
had the same colour when single colonies were picked. 
Among the Vibrio spp. isolated from fish, V. metschnikovii was the most prevalent species. A 
total of 32 V. metschnikovii were isolated from fish, and only three V. alginolyticus. All 
V. metschnikovii from fish were isolated from enrichment cultures, with the exception of one 
isolate. V. metschnikovii was detected in both mackerel and herring, while V. alginolyticus 
was detected only in herring collected in November 2018. As the temperature in Norwegian 
waters in November normally are lower than the preferred temperature for this species, the 
isolation of V. alginolyticus at this time of year may indicate a successful resuscitation of 
viable but non-culturable cells.   
 
Among the examined bivalve molluscs V. anguillarum was the most prevalent species 
isolated, as 87.5 % of the isolates from these samples were identified as V. anguillarum. A 
total of 67 % were isolated from Sample 4, which were blue mussels reared in Nordland. 
From the bivalves, all V. anguillarum were isolated from direct plating of undiluted samples, 
primarily on VCS agar (81 %) after 48 hours of incubation at 37 °C. The remaining three 
isolates were from TCBS agar. Enrichment cultures were set up for each sample, and only one 
sample was positive, and three V. alginolyticus were isolated from this sample. A higher 
diversity of vibrios were expected from these samples because of their filter feeding, but as 
the samples were collected in November, the seawater temperature might have been lower 
than the preferred temperature for vibrios. 
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None of the three major human pathogenic vibrios (V. cholerae, V. vulnificus and V. 
parahaemolyticus) were isolated during this project.  However, according to Ellingsen (2008) 
all three have been isolated from shellfish, and from seawater in the South of Norway when 
the seawater temperature was >17 °C. In the same study, trh positive V. alginolyticus was 
isolated from seawater. 
 
4.3 Antimicrobial resistance  
  
Resistance or reduced susceptibility to one of the tested agents was observed in 79 % of the 
examined vibrios and 60 % showed resistance or reduced susceptibility to two or more agents.  
The most frequently observed resistance among the tested Vibrio spp. was to ampicillin, 
where 74 % were phenotypically resistant to this agent. This included all V. alginolyticus and 
V. anguillarum, 27.3 % of the V. metschnikovii and 28.6 % of the V. aestuarianus. These 
results are consistent with previous studies demonstrating high prevalence of resistance to this 
agent in Vibrio spp. (Hernández-Robles et al., 2016;Pan et al., 2013;Li et al., 1999;Banerjee 
and Farber, 2018;Chiou et al., 2015). The widespread resistance to ampicillin among the 
tested isolates may be explained by the VbrK/VbrR system described in V. parahaemolyticus, 
which controls the expression of a CARB β-lactamase gene which also has been found in 
many Vibrio spp. (Chiou et al., 2015;Li et al., 2016).  In this study, a class A CARB 
β-lactamase was detected in all V. alginolyticus subjected to WGS and in five V. 
metschnikovii. However, one V. metschnikovii showing phenotypic resistance to ampicillin 
did not harbour this gene and among V. anguillarum, a β-lactamase was only detected in one 
of the examined isolates. This indicates the presence of a resistance determinant to ampicillin 
not detected in the databases used in this study. 
 
All V. anguillarum tested during my project displayed reduced susceptibility to imipenem. 
Although imipenem resistant V. anguillarum have been reported (Garcia-Aljaro et al., 2014), 
no literature on the resistance mechanism have been found. When uploading the assembled 
genomes from the eight strains subjected to WGS to the CARD database, one of the isolated 
V. anguillarum showed the presence of a putative V. cholerae varG gene encoding a subclass 
B1-like β-lactamase. The hit gave a 93 % identity to the matching region of varG and 96 % 
identity to the reference sequence. This enzyme belongs to the metallo-β-lactamase class B 
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which can hydrolyse most β-lactam antibiotics, including newer cephalosporins and 
carbapenems (Lin et al., 2017). Carbapenemase producing V. cholerae have also been isolated 
from the marine environment (Bier et al., 2015) and retail shrimp (Mangat et al., 2016). One 
of the isolates showed the presence of a class C β-lactamase gene, encoding enzymes known 
to hydrolyse cephalosporins and penicillins (Jacoby, 2009). This may explain resistance to 
ampicillin in this isolate, but only one isolate was intermediate susceptible to cefotaxime. 
Reduced susceptibility to ampicillin, imipenem and aztreonam was detected in 16 isolates 
tested in this project, one of these also showed reduced susceptibility to cefotaxime. However, 
all of the strains tested during this study were susceptible to meropenem. Additionally, all 
isolates yielded a negative reaction in the carbaNP test, indicating a resistance mechanism 
other than production of carbapenemase.  Furthermore, high prevalence of reduced 
susceptibility to aztreonam (67 %) and erythromycin (25 %) was detected. An RND efflux 
pump was detected in the genomes of the sequenced isolates. However, the specificity of 
these pumps to antibacterial agents have not been examined and it is uncertain if these are 
involved in reduced susceptibility to these agents. 
Among V. metschnikovii, reduced susceptibility was most frequently observed for 
aminoglycosides. The results from this study are in accordance with previous studies of the 
antimicrobial susceptibility of clinical isolates of V. metschnikovii, where resistance to 
ampicillin (Linde et al., 2004), aminoglycosides and third generation cephalosporins have 
been described (Macarena Pariente et al., 2008;Wallet et al., 2005). However, clinical isolates 
have also been shown to respond well to treatment with ampicillin (Hardardottir et al., 1994) 
and to be susceptible to cephalosporins and aminoglycosides (Linde et al., 2004). In 
environmental isolates, resistance to ampicillin, tetracycline, cefoxitin, streptomycin, 
nitrofurantoin and sulfamethoxazole have been described (Garcia-Aljaro et al., 
2014;Rebouças et al., 2011), as well as intermediate susceptibility to aztreonam  (Rebouças et 
al., 2011) has been reported. In this project, reduced susceptibility was observed to ampicillin, 
ceftazidime, cefotaxime, gentamicin, tobramycin and aztreonam. However, newer literature 
regarding the antimicrobial susceptibility profile of environmental V. metschnikovii is quite 
scarce and published studies on the antimicrobial susceptibility of environmental vibrios often 
only include few tested V. metschnikovii. Reduced susceptibility to the highest number of 
antibacterial agents were observed within this species. However, from the sequenced isolates 
from this species no determinants explaining the phenotypic resistance to other agents than 
ampicillin was detected. 
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It is important to note that the control strain was never within the accepted quality control 
(QC) range for gentamicin (appendix D). It is therefore uncertain if the results for the 
aminoglycosides are reliable.  
Reduced susceptibility to oxolinic acid was observed in several of the isolated V. 
alginolyticus.  Resistance to this agent have been described within this species (Scarano et al., 
2014), however the frequency of reduced susceptibility was quite high in my study. All the V. 
alginolyticus subjected to WGS showed the presence of a QnrB  protein and mutations in 
parE, factors known to mediate resistance to quinolones (Hopkins et al., 2005;Jacoby et al., 
2014). Two of the isolates were these determinants were detected displayed phenotypic 
susceptibility to oxolinic acid. No resistance towards ciprofloxacin was observed in this study. 
It is known that only one mutation is not enough to yield resistance to some newer quinolones 
(VKM et al., 2018), such as ciprofloxacin. Based on this study, it seems that mutations in 
parE in combination with QnrB is not sufficient to cause resistance to ciprofloxacin in V. 
alginolyticus. Also, it is worth noting that three of the isolated V. alginolyticus did not grow 
on MHA and susceptibility testing had to be done on MHA supplemented with 1 % NaCl. 
This indicates a requirement for higher NaCl concentrations in these three strains than the rest 
of the strains. 
All V. aestuarianus were resistant to aztreonam, while two isolates were resistant to 
ampicillin and to intermediate susceptible to the same agent. Available literature on the 
susceptibility of environmental vibrios includes only few V. aestuarianus, but resistance to 
ampicillin, oxolinic acid, florfenicol and trimethoprim was seen in one isolate, whereas two 
isolates were resistant to erythromycin (Scarano et al., 2014). All isolates tested during this 
study was susceptible to these agents with the exception of ampicillin. None of the isolated 
V. aestuarianus were whole genome sequenced. 
One or more RND efflux pumps was detected in all the isolates subjected to WGS. It is 
uncertain if these efflux pumps are involved in the reduced susceptibility observed during this 
study. To determine their role, it is necessary to examine their specificity to individual 
antibacterial agents. Furthermore, three different classes of putative β-lactamase genes were 
detected. Class C β-lactamases are known to hydrolyse cephalosporins (Jacoby, 2009). This 
was not seen in the disk diffusion test in the isolates were this β-lactamase gene was found. A 
putative subclass B3 β-lactamase gene was detected in five V. alginolyticus, and these are 
active against penicillins, cephalosporins and carbapenems (Palzkill, 2013). This does not 
correspond to the results from phenotypic susceptibility testing. Differences between 
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phenotypic and genetic susceptibility has been reported and may be caused by variable 
expression in tested isolates, leading to difficulties in phenotypic detection (Sundsfjord et al., 
2004). Further studies should be done to examine the presence of these, their activity against 
antibacterial agents, and significance in antibacterial resistance in the aquatic environment. 
Of the tested agents in this study, florfenicol and oxolinic acid are the only ones used in 
aquaculture in Norway the last ten years. Penicillins are the most sold antibacterial class for 
food producing animals, and for human use, narrow spectrum penicillins and tetracycline are 
the most sold agents (NORM/NORM-VET, 2017). Of these antibiotic classes, resistance was 
observed against oxolinic acid in V. alginolyticus and V. metschnikovii, and broad-spectrum 
penicillins in all the tested species, thus only to ampicillin. Resistance to oxolinic acid have 
previously been reported in aquatic bacteria (Ervik et al., 1994;Guardabassi et al., 2000). 
However, it is important to note that the breakpoints used to determine the susceptibility to 
this agent applies for A. salmonicida and a lower incubation temperature and longer 
incubation time. Further studies are necessary to determine if these breakpoints are applicable 
to Vibrio spp. and the conditions used during this study. 
 
The results in this study shows differences in resistance patterns within the species, especially 
among the isolated V. metschnikovii. There are several sources for the spread of antibiotics to 
the aquatic environment, such as through wastewater and run-off from land (Berglund, 
2015;Baquero et al., 2008), and resistant bacteria other than vibrios can be disseminated by 
the same routes. This can result in the spread of resistance among bacteria, possibly 
explaining the differences in susceptibility within the examined species. 
 
The most interesting resistance observed during this project was against imipenem in isolated 
V. anguillarum. Imipenem is a carbapenem antibiotic, a class considered to be critically 
important in human medicine by the WHO (WHO, 2017b). All resistant isolates were 
recovered from bivalves, which may function as a hotspot for exchange of genetic material 
(Grevskott et al., 2017). These findings may indicate a possibility of exchange of 
determinants conferring resistance to imipenem between bacteria, including human 
pathogenic bacteria, present in the marine environment, and the transfers between different 
niches through bivalves. These bacteria can eventually cause foodborne infections in humans. 
Even though a carbapenem hydrolysing β-lactamase was detected in one of the isolates, this 
does not comply with - or explain the results seen in this study. It is unknown if resistance to 
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this agent is caused by an intrinsic mechanism or one acquired and transferable through HGT.  
Further studies are necessary to determine the underlying mechanism and significance of this 
discovery. Furthermore, the detection of a putative class B β-lactamase gene in several 
isolated V. alginolyticus is highly interesting as this species is considered human pathogenic.  
The breakpoints in the standard method used to assess the antimicrobial susceptibility of the 
isolates tested in this study applies for Enterobacteriaceae and an incubation temperature of 
35 °C for 16-18 hours. For the agents oxolinic acid, florfenicol and erythromycin, the 
breakpoints and ECOFF values applies for A. salmonicida when tested at 22 °C and incubated 
for 44-48 hours. This means that the method used for susceptibility testing in this project is 
not specific for the breakpoints, and the results from phenotypic susceptibility testing should 
be interpreted with some precautions. Further analysis of the genomes is necessary to 
determine the activity and significance of detected mechanisms, and to locate undetected 
antibiotic resistance determinants.  
When reading the inhibition zones, double zones were observed for erythromycin and 
azithromycin in several of the tested strains of V. metschnikovii and V. alginolyticus. This 
caused difficulties in the precision when measuring the zones. This phenomenon was 
particularly observed for several agents when testing the antimicrobial susceptibility of V. 
alginolyticus. This species swarms on solid media, and caused difficulties in determining the 
exact zone diameter, and the outer zone was regarded as the inhibition zone. Weak growth 
was observed on MHA plates for several of the tested species, and this caused difficulties in 
measuring of inhibition zones. This is a factor possibly affecting the results, and may be due 
to a to low NaCl concentration or to low density in the inoculum spread on the plates. 
When tested on MHA supplemented with 1 % NaCl reduced inhibition zones were observed 
for most of the agents for all species. The most notable change was observed for the 
cephalosporins and aztreonam. For cefotaxime, a change from susceptible to intermediate or 
resistant, or intermediate susceptible to resistant, was observed within all the tested species. 
The same pattern was observed for ceftazidime among V. metschnikovii and V. anguillarum. 
For aztreonam, members of all the species showed reduced inhibition zones and isolates 
previously susceptible or intermediate susceptible were categorized as resistant or 
intermediate susceptible to this agent. However, one of the V. metschnikovii changed from 
intermediate to sensitive for ceftazidime, cefotaxime and aztreonam, when examined on MHA 
with 1 % NaCl. This may indicate that this isolate was in a mixed culture.  
70 
 
The effect of a higher NaCl concentration in MHA on both the growth of bacteria and the 
activity of the antimicrobial agents has not been studied in detail (CLSI, 2006). Addition of 
NaCl will also change the osmolarity in the medium and could affect the diffusion rate of the 
antibiotics into the agar (CLSI, 2006). This is known to have a marked effect on the 
aminoglycosides (Medeiros et al., 1971;Lamb et al., 1972). As no determinants explaining 
resistance to these agents in isolates subjected to WGS, it is likely that the increased 
frequency of resistance to aztreonam and cephalosporins was at least partially caused by the 
effects of NaCl on the media and/or the antibacterial agents. However, further studies on 
susceptibility testing of halophilic bacteria is necessary. Currently, no QC data exists for 
antimicrobial susceptibility testing using MHA supplemented with NaCl, and it is therefore 
not possible to assure the quality of the agar and disks when testing on media supplemented 
with NaCl. No specific protocols exist for interpretation of inhibition zones when using media 
with additional salt. 
A recently published study concluded that antimicrobial susceptibility testing of Vibrio spp., 
including V. alginolyticus, should be done using unmodified MHA (Smith and Egan, 2018). 
MHA contains hydrolysate from casein which has enough NaCl to allow the growth of most 
halophilic Vibrio species (Dworkin et al., 2006;Smith and Egan, 2018). However, during this 
project not all isolated V. alginolyticus did grow on MHA without the addition of 1 % NaCl. 
This may lead to problems when conducting large studies on antimicrobial susceptibility of 
Vibrio spp., as it is important that all testing is performed under standardized conditions. 
Thus, it is necessary to establish a standardized protocol for antimicrobial susceptibility 
testing of vibrios which enables testing of all members of a species using the same protocol. 
For future studies, it should be considered performing broth dilution susceptibility testing in 
Mueller Hinton broth (MHB), as this will allow the determination of an MIC value. Using 
MHB would also remove the problem with double zones, and the swarming of 
V. alginolyticus on solid media. 
 
4.4 Hemolytic activity 
 
Hemolysins are considered virulence factors in several Vibrio spp., including 
V. metschnikovii. The hemolysin produced by this species has been showed to lyse cells from 
several animals, including humans, sheep and horse (Miyake et al., 1988). Hemolytic activity 
was observed in all isolated V. metschnikovii on both TSA with 5 % sheep- and human blood. 
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The results indicate that sheep erythrocytes are more susceptible to this hemolysin as β-
hemolysis was observed on agar containing sheep blood only. This is conflicting to previous 
studies showing that this species seems to have low activity on sheep blood, and that human 
erythrocytes are more susceptible to hemolysins produced by V. metschnikovii (Matté et al., 
2007).  During the present study, tlh- and hlyA related genes were detected in all strains 
subjected to WGS, and in one isolate two tlh- and hlyA related genes, an additional hemolysin 
and RTX encoding genes were detected. TLH is a hemolysin previously described as 
virulence factor in Vibrio spp., such as in environmental V. alginolyticus (Hernández-Robles 
et al., 2016). HlyA, also known as V. cholerae  cytolysin (VCC), is a pore forming hemolysin 
and cytolysin with activity against a range of eukaryotic cells (Ruenchit et al., 2017) and is 
found in both V. cholerae O1 and nonO1/nonO139 (Gutierrez et al., 2007;Elluri et al., 2014). 
Cytotoxic activity has previously been described in V. metschnikovii isolated from a leg 
wound (Linde et al., 2004). Even though V. metschnikovii have caused infections in humans, 
this species is poorly described with regards to virulence factors. However, the presence of 
these genes may indicate a pathogenic potential. RTX is a pore forming toxin found in several 
pathogenic Gram-negative bacteria (Lee et al., 2008) possibly indicating a higher pathogenic 
potential in this strain. No difference in hemolytic activity was observed from isolated V. 
metschnikovii from water and fish.  
 
No hemolytic activity was observed on agar containing neither sheep- or human blood among 
the tested V. alginolyticus. In all V. alginolyticus a tlh related gene was identified. The role of 
TLH in human infections is unknown, but it is upregulated under conditions simulating those 
in the human intestine (Gutierrez West et al., 2013;Schwartz et al., 2019). A previous study 
have demonstrated that sheep erythrocytes are not very sensitive to TLH (Jia et al., 2010), 
possibly explaining the lack of hemolysis observed on blood agar. Based on the results from 
this study, the TLH detected seems to have low or no activity to human erythrocytes and that 
HlyA was responsible for the hemolysis on blood agar caused by V. metschnikovii. 
In V. anguillarum, hlyA-, tlh- and rtx related genes were detected, but this species is not 





5 Conclusion  
 
Totally, 135 Vibrio spp. was isolated from seawater, fish and bivalves, 64 V. alginolyticus, 38 
V. metschnikovii, 24 V. anguillarum and seven V. aestuarianus. Also, two V. cincinnatiensis 
was isolated, but the identity of these needs confirmation.   
API 20E was not ideal for identification of environmental vibrios, while MALDI-TOF MS 
proved to be a valuable tool for identification of members of this genus. The rpoB sequencing 
gave identification with low confidence.   
High prevalence of phenotypic resistance or reduced susceptibility was observed to 
ampicillin, aztreonam, oxolinic acid, tobramycin and imipenem. Addition of 1 % NaCl to 
MHA resulted in smaller inhibition zones for all agents. WGS revealed the presence of 
different classes of putative β-lactamase genes in the isolated vibrios, QnrB proteins, parE 
conferring resistance to quinolones and RND efflux pumps. These does however not explain 
the results from phenotypic susceptibility testing and further studies are necessary to 
determine the activity and significance of these resistance mechanisms. Resistance to 
clinically important antibacterial agents, such as tetracycline and cephalosporins, in vibrios 
have been reported (Hernández-Robles et al., 2016;Letchumanan et al., 2015;Lee et al., 2018). 
However, this study demonstrates a low prevalence of resistance to these agents in vibrios 
isolated from the Norwegian marine environment. 
All isolated V. metschnikovii were hemolytic on agar containing sheep- or human blood and 
contained tlh- and hlyA related genes. V. alginolyticus was not hemolytic on blood agar, but a 
tlh related gene was identified. 
The results from this study indicates a risk of exposure to potentially pathogenic vibrios 
through bathing, consumption- and handling of raw seafood, as well as the transfer of 
resistant bacteria to the human food chain.  Furthermore, a link between SST, salinity and 
occurrence of Vibrio spp. was seen. The prevalence of human pathogenic vibrios are shown to 
be highly dependent on SST, and as the sea temperature is expected to keep increasing due to 
global warming (EEA, 2017), the conditions in the ocean will become more favourable for 
Vibrio spp. Thus, there is a need to establish a surveillance programme of public bathing areas 
and of bivalve molluscs intended for human consumption when the water temperatures 
exceed 18-20 °C, as there is no correlation between commonly measured fecal indicator 
bacteria and Vibrio spp. (Lunestad and Rosnes, 2018). 
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The role of the aquatic environment in the spread of antibiotic resistance is largely unknown. 
Thus, it is necessary to establish standardized protocols for antimicrobial susceptibility testing 





6. Further studies 
 
For future studies regarding the occurrence and characteristics of Vibrio spp. in Norwegian 
waters, the study should be conducted over a longer period of time, and cover larger parts of 
the Norwegian coast, especially along the South coast where these bacteria have caused 
infections when temperatures exceeds 20 °C.  A standardized method for the analysis and 
enrichment of water samples from public bathing areas and locations used for farming of 
bivalve molluscs, should be developed to monitor the occurrence of these bacteria in such 
areas.  
Further studies on the pathogenic potential of V. metschnikovii should be conducted, as this 
was a frequently isolated species which previously have caused infections in humans. 
This study has shown that antimicrobial susceptibility testing of environmental vibrios can be 
challenging as the test media used in standard protocols contains an insufficient concentration 
of NaCl to support the growth of all isolated strains. Further work should therefore focus on 
establishing standardized methods for antimicrobial testing of Vibrio spp., and not only those 
considered to be major human pathogens. It is necessary to standardize test conditions, as well 
as establishing breakpoints, MIC- and ECOFF values to both monitor resistance within in the 
genus Vibrio, as well as the role of the marine environment in the dissemination of antibiotic 
resistance. Future work on the antimicrobial susceptibility of vibrios should be conducted 
using the broth dilution method as this method allows the determination of each tested isolates 
MIC value to each of the tested agents. Experiments to examine the ability of these bacteria to 
both transfer and acquire genes conferring resistance towards antibacterial agents through 
horizontal gene transfer should be performed.  
Due to time limitations, only a preliminary analysis of the sequenced genomes was conducted. 
Further in-depth studies should be done on these genomes to try to explain the phenotypic 
resistance observed in this study. Furthermore, more work should be done to examine the 
significance of the putative class B β-lactamase gene detected in V. alginolyticus as this may 
indicate an acquired- and clinically significant resistance mechanism in these isolates which 
are considered to be human pathogenic. As all isolated V. anguillarum were phenotypic 
resistant or intermediate susceptible to imipenem, further studies should be conducted to 
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8.1 Appendix A. Measured temperature, pH and Salinity in water samples 
 
-: Missing measurement 
Sample no. Location Depth Temperature (°C) pH Salinity (‰) 
1 1 Surface 16 7.721 12.4 
2 1 2 m 15 7.734 16.9 
3 1 5 m 9 7.821 31.1 
4 1 7 m 8 7.849 32.1 
5 1 10 m 7 7.860 32.2 
6 2 Surface 12 7.982 31.4 
7 2 2 m 12 7.862 31.3 
8 2 5 m 10 7.890 31.9 
9 2 7 m 9 7.878 32.2 
10 2 10 m 8.5  -  - 
11 3 Surface 14 7.880 31.8 
12 3 2 m 14 7.883 31.1 
13 3 5 m 14 7.887 31 
14 3 7 m 12.5 7.893 31.9 
15 3 10 m 11 7.956 34.3 
16 4 Surface 13 7.886 31.6 
17 4  2 m 13 7.878 31.1 
18 4 5 m 13 7.964 31.2 
19 4 7 m 13 7.893 31.1 
















8.2 Appendix B. Identification by API 20E 
 
API 20E 
Isolate Bacterium Identification (%) T-value 
1-1 (4) V. alginolyticus   97.8 0.74 
1-1 (4-a) V. alginolyticus   97.8 0.74 
1-1 (7) A. hydrophila/caviae/sobria 1     37.3 0.33 
1-1 (8) V. alginolyticus  97.8 0.74 
1-2 (2) A. hydrophila/caviae/sobria 1     63.4 0.69 
1-2 (3) A. hydrophila/caviae/sobria 2    68.7 0.67 
1-2 (3-a) V. cholerae (presumptive ID) 98.5 0.71 
1-2 (4) V. cholerae (presumptive ID) 98.5 0.71 
1-2 (5) Identification not valid     
1-2 (6)  A. hydrophila/caviae/sobria 1     63.4 0.64 
1-2 (7) V. alginolyticus   85.9 0.81 
1-2 (7-a) V. alginolyticus   97.8 0.74 
1-2 (8) P. pneumotropica/M. haemolytica  94.8 0.39 
1-2 (9)  A. hydrophila/caviae/sobria 2    63.4 0.69 
1-3 (1) V. alginolyticus   85.9 0.81 
1-3 (1-a) V. alginolyticus  85.9 0.81 
1-3 (2) V. alginolyticus   85.9 0.81 
1-3 (2-a) V. alginolyticus   95.4 0.74 
1-3 (3) Unacceptable profile     
1-3 (4) V. fluvialis 56.5 0.52 
1-3 (4-a) V. alginolyticus   85.9 0.81 
1-3 (4-b) V. alginolyticus   85.9 0.81 
1-3 (5) V. alginolyticus   95.4 0.74 
1-3 (6) V. alginolyticus   97.8 0.74 
1-3 (6-a) V. alginolyticus   97.8 0.74 
1-3 (7) V. alginolyticus   97.8 0.74 
1-3 (8) Low discrimination. Vibrio sp.  49.7 0.53 
1-3 (10) V. alginolyticus   97.8 0.74 
1-4 (1) V. cholerae (presumptive ID) 98.5 0.71 
1-4 (2) V. cholerae (presumptive ID) 94.6 0.43 
2-1 (2) A. hydrophila/caviae/sobria 2       68.7 0.67 
2-1 (2-a) V. cholerae (presumptive ID) 98.5 0.71 
2-1 (5) V. alginolyticus  97.8 0.74 
2-1 (6) V. alginolyticus   99.7 0.81 
2-1 (6-a) V. alginolyticus   99.3 0.66 
2-1 (7) V. alginolyticus  97.8 0.74 
2-1 (7-a) V. alginolyticus   99.3 0.66 
2-1 (9) V. alginolyticus   97.8 0.74 
2-2 (2) V. alginolyticus   85.9 0.81 
2-2 (2-a) V. alginolyticus   85.9 0.81 
2-2 (3) V. alginolyticus   85.9 0.81 
2-2 (3-a) V. alginolyticus   85.9 0.81 
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2-2 (7) V. alginolyticus   85.9 0.81 
2-2 (8) Identification not valid     
2-2 (9) V. alginolyticus   97.8 0.74 
2-3 (1) V. alginolyticus  85.9 0.81 
2-3 (3) P. pneumotropica/M. haemolytica 84.1 0.69 
2-3 (3-a) P. damselae 99.2 0.44 
2-3 (5) V. alginolyticus   97.8 0.74 
2-3 (5-a) V. alginolyticus   97.8 0.74 
2-3 (6) V. alginolyticus   99.3 0.66 
2-3 (6-a) V. alginolyticus   97.8 0.74 
2-3 (9) V. alginolyticus   99.3 0.66 
2-3 (9-a) V. alginolyticus  85.9 0.81 
3-1 (1) V. alginolyticus  97.8 0.74 
3-1 (1-a) V. alginolyticus   99.3 0.66 
3-2 (1) A. hydrophila/caviae/sobria 2  69.86 0.28 
4-1 (2) V. alginolyticus  97.8 0.74 
4-2 (2) V. alginolyticus  97.8 0.74 
4-2 (5)  P. pneumotropica/M. haemolytica     57.7 0.69 
4-3 (1) V. alginolyticus  97.8 0.74 
4-3 (1-a) P. pneumotropica/M. haemolytica  34.4 0.64 
4-3 (2) V. alginolyticus  97.8 0.74 
4-5 (1) V. alginolyticus  95.4 0.74 
4-5 (1-a) V. alginolyticus  97.8 0.74 
4-5 (2) V. alginolyticus  85.9 0.81 
5-1 (1) Unacceptable profile     
5-1 (2) Unacceptable profile     
5-1 (4) V. Cholerae  89.8 0.41 
5-2 (1) A. hydrophila/caviae/sobria 2    89.3 0.49 
5-2 (2) Unacceptable profile     
5-2 (3) A. hydrophila/caviae/sobria 2    89.3 0.49 
5-3 (1) Unacceptable profile     
6-2 (1) A. hydrophila/caviae/sobria 2    89.3 0.49 
6-3 (1) Unacceptable profile     
7-5 (1) Unacceptable profile     
7-5 (1-a) V. alginolyticus   85.9 0.81 
8-1 (1) V. alginolyticus   85.9 0.81 
8-1 (1-a) Unacceptable profile     
11-4 (1) V. alginolyticus   85.9 0.81 
11-4 (1-a) Unacceptable profile     
12-2 (3) Unacceptable profile     
12-2 (3-a) Unacceptable profile     
A2-1 V. fluvialis 93.5 0.51 
A2-2 Identification not valid     
A5-1 P. pneumotropica/M. haemolytica 99.2 0.47 
A5-2 P. pneumotropica/M. haemolytica 96.3 0.42 
A6 A. hydrophila/caviae/sobria 2    89.3 0.49 
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A7 A. hydrophila/caviae/sobria 2    89.3 0.49 
A8-1 Identification not valid     
A8-2 P. pneumotropica/M. haemolytica 85.1 0.44 
A9 A. hydrophila/caviae/sobria 2    89.3 0.49 
A10 A. hydrophila/caviae/sobria 2    89.3 0.49 
A11 Unacceptable profile     
A12 A. hydrophila/caviae/sobria 2    89.3 0.49 
A13 P. pneumotropica/M. haemolytica 96.2 0.42 
A14 P. pneumotropica/M. haemolytica 96.3 0.42 
A15 A. hydrophila/caviae/sobria 2    89.3 0.49 
A17 A. hydrophila/caviae/sobria 2    89.3 0.49 
A19 P. pneumotropica/M. haemolytica 96.3 0.42 
TA 2 P. pneumotropica/M. haemolytica  96.2 0.42 
TA 4-1 Unacceptable profile     
TA 4-2 Unacceptable profile     
TA 5 Unacceptable profile     
TA 6 P. pneumotropica/M. haemolytica  96.2 0.42 
TA 7 P. pneumotropica/M. haemolytica  96.2 0.42 
TA 8 P. pneumotropica/M. haemolytica  96.2 0.42 
TA 11 P. pneumotropica/M. haemolytica  96.2 0.42 
TA 12 P. pneumotropica/M. haemolytica 96.2 0.42 
TA 13 Unacceptable profile     
TA 14 K. pneumoniae ssp rhinoscleromatis  85.1 0.42 
TA 16 A. hydrophila/caviae/sobria 2    89.3 0.49 
TA 17 P. pneumotropica/M. haemolytica 96.2 0.42 
TA 20 P. pneumotropica/M. haemolytica 96.2 0.42 
TS 2 Unacceptable profile     
TS 4 A. hydrophila/caviae/sobria 2    94.3 0.26 
TS 6 A. hydrophila/caviae/sobria 2    89.3 0.49 
TS 8 Unacceptable profile     
TS 18-1 Proteus vulgaris group  99.9 0.93 
TS 18-2 Proteus vulgaris group  99.2 0.93 
TS 20 P. pneumotropica/M. haemolytica  96.2 0.42 
GA 2 A. hydrophila/caviae/sobria 2    89.3 0.49 
GA 3 Unacceptable profile     
GA 4 P. pneumotropica/M. haemolytica  96.3 0.42 
GA 5 A. hydrophila/caviae/sobria 2    89.3 0.49 
GA 6 P. pneumotropica/M. haemolytica  96.2 0.42 
GA 7 P. pneumotropica/M. haemolytica  96.2 0.42 
GA 8 P. pneumotropica/M. haemolytica  96.2 0.42 
GA 9 V. Cholerae 89.8 0.41 
GA 10 V. Cholerae 89.8 0.41 
GA 11 P. pneumotropica/M. haemolytica  85.4 0.28 
GA 13 A. hydrophila/caviae/sobria 2    89.3 0.49 
GA 14 A. hydrophila/caviae/sobria 2    87.2 0.23 
GA 15 P. pneumotropica/M. haemolytica  96.2 0.42 
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GA 16 P. pneumotropica/M. haemolytica  96.2 0.42 
GA 17 P. pneumotropica/M. haemolytica  96.2 0.42 
GA 18-2 Unacceptable profile     
GA 19 P. pneumotropica/M. haemolytica  96.2 0.42 
GA 20 A. hydrophila/caviae/sobria 2    89.3 0.49 
GS 15 Unacceptable profile     
T.2 A12 Unacceptable profile     
T.2 A16 A. hydrophila/caviae/sobria 2    89.6 0.49 
T.2 A17 Aeromonas hydrophila/caviae/sobria 1 51.8 0.28 
T.2 T7  A. hydrophila/caviae/sobria 2    98.8 0.49 
T.3 A1 S. putrefaciens group 99.7 0.9 
T.3 A2 V.alginolyticus 92.1 0.66 
T.3 A5 S. putrefaciens group 99.7 0.9 
T.3 A7 S. putrefaciens group 99.7 0.9 
T.3 A9 S. putrefaciens group 99.7 0.9 
T.3 A14 V.alginolyticus 92.1 0.66 
T.3 A15 S. putrefaciens group 99.9 0.42 
T.3 A19 V.alginolyticus 97.8 0.74 
T.3 A20 V.alginolyticus 97.8 0.74 
B1-2  Aeromonas hydrophila/caviae/sobria 1 54.2 0.36 
B1-4 A. hydrophila/caviae/sobria 2    70.5 0.56 
B4-1  A. hydrophila/caviae/sobria 2    70.5 0.56 
B4-3  A. hydrophila/caviae/sobria 2    70.5 0.56 
B4-4  A. hydrophila/caviae/sobria 2   70.5 0.56 
B4-5  A. hydrophila/caviae/sobria 2    70.5 0.56 
B4-6  A. hydrophila/caviae/sobria 2    70.5 0.56 
B4-7  A. hydrophila/caviae/sobria 2    70.5 0.56 
B4-8  A. hydrophila/caviae/sobria 2    70.5 0.56 
B4-9  A. hydrophila/caviae/sobria 2    61.2 0.28 
B4-10  A. hydrophila/caviae/sobria 2    87.3 0.56 
B4-11  A. hydrophila/caviae/sobria 2    70.5 0.56 
B4-12  A. hydrophila/caviae/sobria 2    70.5 0.56 
B4-13  A. hydrophila/caviae/sobria 2    70.5 0.56 
B4-14  A. hydrophila/caviae/sobria 2    70.5 0.56 
B4-15  A. hydrophila/caviae/sobria 2    70.5 0.56 
B4-16  A. hydrophila/caviae/sobria 2    70.5 0.56 
B4  A. hydrophila/caviae/sobria 2    70.5 0.56 
B7  A. hydrophila/caviae/sobria 2    70.5 0.56 
B8-1  A. hydrophila/caviae/sobria 2    70.5 0.56 
B8-2  A. hydrophila/caviae/sobria 2    70.5 0.56 
B9-1  V. alginolyticus 95.8 0.76 
B9-2  V. alginolyticus 92.1 0.66 





8.3 Appendix C. Identification by MALDI-TOF MS 
 
MALDI-TOF 
Isolate Bacterium Score 
1-1 (4) V. alginolyticus   2,24 
1-1 (4-a) V. alginolyticus   2,29 
1-1 (7) V. anguillarum 2,32 
1-1 (8) V. alginolyticus   2,22 
1-2 (2) V. aestuarianus 2,46 
1-2 (3) V. alginolyticus   2,19 
1-2 (3-a) V. alginolyticus   2,19 
1-2 (4) V. alginolyticus   2,19 
1-2 (5) S. hominis 2,32 
1-2 (6)  V. aestuarianus 2,35 
1-2 (7) V. alginolyticus   2,17 
1-2 (7-a) V. alginolyticus   2,21 
1-2 (8) V. aestuarianus 2,43 
1-2 (9)  S. hominis 2,3 
1-3 (1) V. alginolyticus   2,12 
1-3 (1-a) V. alginolyticus   2,21 
1-3 (2) V. alginolyticus   2,05 
1-3 (2-a) V. alginolyticus   2,17 
1-3 (3) V. alginolyticus   2,1 
1-3 (4) V. alginolyticus   2,48 
1-3 (4-a) V. alginolyticus   2,21 
1-3 (4-b) V. alginolyticus   2,15 
1-3 (5) V. alginolyticus   2,18 
1-3 (6) V. alginolyticus   2,11 
1-3 (6-a) V. alginolyticus   2 
1-3 (7) V. alginolyticus   2 
1-3 (8) V. aestuarianus 2,29 
1-3 (10) V. alginolyticus   1,93 
1-4 (1) V. alginolyticus   2,18 
1-4 (2) V. alginolyticus   2,1 
2-1 (2) V. alginolyticus   2,21 
2-1 (2-a) V. alginolyticus   2,13 
2-1 (5) V. alginolyticus   2,21 
2-1 (6) V. alginolyticus   2,14 
2-1 (6-a) V. alginolyticus   2,19 
2-1 (7) V. alginolyticus   2,2 
2-1 (7-a) V. alginolyticus   2,23 
2-1 (9) V. alginolyticus   1,84 
2-2 (2) V. alginolyticus   2,09 
2-2 (2-a) V. alginolyticus   2 
2-2 (3) V. alginolyticus   2,11 
2-2 (3-a) V. alginolyticus   2,13 
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2-2 (7) V. alginolyticus   2,21 
2-2 (8) V. anguillarum 2,37 
2-2 (9) V. alginolyticus   2,19 
2-3 (1) V. alginolyticus   2,2 
2-3 (3) V. aestuarianus 2,37 
2-3 (3-a) S. warneri 2,22 
2-3 (5) V. alginolyticus   2,14 
2-3 (5-a) V. alginolyticus   2,13 
2-3 (6) V. alginolyticus   2,17 
2-3 (6-a) V. alginolyticus   2,19 
2-3 (9) V. alginolyticus   2,12 
2-3 (9-a) V. alginolyticus   2,29 
3-1 (1) V. alginolyticus   2,14 
3-1 (1-a) V. alginolyticus   2,23 
3-2 (1) V. anguillarum 2,37 
4-1 (2) V. alginolyticus   2,16 
4-2 (2) V. alginolyticus   2,11 
4-2 (5) V. aestuarianus 2,35 
4-3 (1) V. alginolyticus   2,12 
4-3 (1-a) V. aestuarianus 2,43 
4-3 (2) V. alginolyticus   2,14 
4-5 (1) V. alginolyticus   2,16 
4-5 (1-a) V. alginolyticus   2,23 
4-5 (2) V. alginolyticus   2,17 
5-1 (1) P.vulgaris 2,49 
5-1 (2) P.vulgaris 2,41 
5-1 (4) V. metschnikovii 1,82 
5-2 (1) V. metschnikovii 1,75 
5-2 (2) V. metschnikovii 1,75 
5-2 (3) V. metschnikovii 1,7 
5-3 (1) P. vulgaris 2,53 
6-2 (1) V. metschnikovii 1,73 
6-3 (1) P. vulgaris 2,55 
7-5 (1) V. metschnikovii 1,85 
7-5 (1-a) V. alginolyticus   2,11 
8-1 (1) V. alginolyticus   2,12 
8-1 (1-a) V. alginolyticus   2,17 
11-4 (1) V. alginolyticus   2,13 
11-4 (1-a) P. vulgaris 2,4 
12-2 (3) No organism identification possible   
12-2 (3-a) No organism identification possible   
A2-1 V. metschnikovii 1,87 
A2-2 V. metschnikovii 1,77 
A5-1 No organism identification possible   
A5-2 No organism identification possible   
A6 V. metschnikovii 1,75 
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A7 V. metschnikovii 1,74 
A8-1 No organism identification possible 1,78 
A8-2 V. metschnikovii 1,85 
A9 V. metschnikovii 1,73 
A10 V. metschnikovii 1,78 
A11 V. metschnikovii 1,73 
A12 V. metschnikovii 1,75 
A13 No organism identification possible   
A14 No organism identification possible   
A15 V. metschnikovii 1,85 
A17 V. metschnikovii 1,8 
A19 No organism identification possible   
TA 2 No organism identification possible   
TA 4-1 V. metschnikovii 1,9 
TA 4-2 V. metschnikovii 1,84 
TA 5 V. metschnikovii 1,83 
TA 6 No organism identification possible   
TA 7 No organism identification possible   
TA 8 No organism identification possible   
TA 11 No organism identification possible   
TA 12 No organism identification possible   
TA 13 V. metschnikovii 1,76 
TA 14 No organism identification possible   
TA 16 V. metschnikovii 1,81 
TA 17 No organism identification possible   
TA 20 No organism identification possible   
TS2 V. metschnikovii 1,72 
TS 4 V. metschnikovii 1,75 
TS 6 V. metschnikovii 1,83 
TS 8 No organism identification possible   
TS 18-1 P. vulgaris 2,33 
TS 18-2 P. vulgaris 2,23 
TS 20 No organism identification possible   
GA 2 No organism identification possible   
GA 3 No organism identification possible   
GA 4 No organism identification possible   
GA 5 V. metschnikovii 1,84 
GA 6 No organism identification possible   
GA 7 No organism identification possible   
GA 8 No organism identification possible   
GA 9 V. metschnikovii 1,87 
GA 10 V. metschnikovii 1,85 
GA 11 No organism identification possible   
GA 13 V. metschnikovii 1,73 
GA 14 V. metschnikovii 1,82 
GA 15 No organism identification possible   
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GA 16 V. metschnikovii 1,77 
GA 17 No organism identification possible   
GA 18-2 No organism identification possible   
GA 19 No organism identification possible   
GA 20 V. metschnikovii 1,78 
GS 15 V. metschnikovii 1,87 
T.2 A12 V. metschnikovii 1,73 
T.2 A16 V. metschnikovii 1,79 
T.2 A17 V. metschnikovii 1,77 
T.2 T7  V. metschnikovii 1,81 
T.3 A1 S. putrefaciens 2,34 
T.3 A2 V. alginolyticus 2,15 
T.3 A5 S. putrefaciens 2,27 
T.3 A7 P. hauseri 2,39 
T.3 A9 S. putrefaciens 2,42 
T.3 A14 V. alginolyticus 2,24 
T.3 A15 S. putrefaciens 2,35 
T.3 A19 V. alginolyticus 2,09 
T.3 A20 V. alginolyticus 2,06 
B1-2  V. anguillarum 2,32 
B1-4  V. anguillarum 2,36 
B4-1  V. anguillarum 2,4 
B4-3  V. anguillarum 2,36 
B4-4  V. anguillarum 2,39 
B4-5  V. anguillarum 2,4 
B4-6  V. anguillarum 2,39 
B4-7  V. anguillarum 2,32 
B4-8  V. anguillarum 2,4 
B4-9  V. anguillarum 2,47 
B4-10  V. anguillarum 2,41 
B4-11  V. anguillarum 2,42 
B4-12  V. anguillarum 2,38 
B4-13  V. anguillarum 2,42 
B4-14  V. anguillarum 2,33 
B4-15  V. anguillarum 2,38 
B4-16  V. anguillarum 2,4 
B4  V. anguillarum 2,37 
B7  V. anguillarum 2,48 
B8-1  V. anguillarum 2,38 
B8-2  V. anguillarum 2,3 
B9-1  V. alginolyticus 2,18 
B9-2  V. alginolyticus 2,1 





8.4 Appendix D. Quality control measurements for antimicrobial susceptibility testing 
at 28 °C 
 
- : No measurement 
  Quality control (E. coli CCUG 17620). Inhibition zone (mm) 
Date AMP E CN OA SXT FFC 
05.12 17 10 20 30 31 22 
07.12 #1 16 10 20 28 31 23 
07.12 #2 19  - 20 27  - 22 
09.12 #1 16 10 20 28 29 23 
09.12 #2 18 11 21 29 31 22 
11.12 19 10 21 28 32 22 
14.12#1 16 10 19 27 32 23 
14.12#2 17 9 20 27 32 24 
18.12 #1 19 10 19 27 29 22 
18.12#2 16 10 19 27 29 21 
 
 
8.5 Appendix E. Quality control measurements for antimicrobial susceptibility testing 
at 22 °C 
 
  Quality control (E. coli CCUG 17620). Inhibition zone (mm) after 24 h 
Date AMP E CN OA SXT FFC 
7/1 15 15 22 32 36 26 
15/1 16 15 22 31 34 23 
 
 
  Quality control (E. coli CCUG 17620). Inhibition zone (mm) after 48 h 
Date AMP E CN OA SXT FFC 
7/1 12 15 21 32 34 24 





8.6 Appendix F. MIC for imipenem 
 
MIC for Imipenem  
Isolate MIC (µg/ml) 
B1-2  4 
B1-4  8 
B4-1  4 
B4-3  8 
B4-4  4 
B4-5  8 
B4-6  8 
B4-7  8 
B4-8  8 
B4-9  8 
B4-10  4 
B4-11  4 
B4-12  4 
B4-13  4 
B4-14  4 
B4-15  4 
B4-16  2 
B4  4 
B7  4 
B8-1  8 
B8-2  4 
1-1 (7) 4 
2-2 (8) 2 





8.7 Appendix G. Hemolytic activity of V. metschnikovii on blood agar 
 
 Hemolysis 
  Sheep blood Human blood 
Isolate α β α β 
5-1 (4) - + + - 
5-2 (1) + - + - 
5-2 (2) + - + - 
5-2 (3) + - + - 
6-2 (1) + - + - 
7-5 (1) + - + - 
A2-1 + - + - 
A2-2 + - + - 
A6 + - + - 
A7 + - + - 
A8-1 + - + - 
A8-2 + - + - 
A9 + - + - 
A10 + - + - 
A11 + - + - 
A12 + - + - 
A15 - + + - 
A17 + - + - 
TA 4-1 + - + - 
TA 4-2 + - + - 
TA 5 + - + - 
TA 13 + - + - 
TA 16 + - + - 
TS2 + - + - 
TS 4 + - + - 
TS 6 + - + - 
GA 5 + - + - 
GA 9 + - + - 
GA 10 + - + - 
GA 13 + - + - 
GA 14 + - + - 
GA 16 - + + - 
GA 20 - + + - 
GS 15 + - + - 
A12 (T.2) + - + - 
A16 (T.2) + - + - 
A17 (T.2) + - + - 
T7 u.f (T.2) + - + - 
2017-1457/9 + - + - 
2017-1457/10 + - + - 
2017-1457/11 + - + - 
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2017-1457/13 + - + - 
2017-1457/15 + - + - 
2017-1457/20 - + + - 
 
 
8.8 Appendix H. Hemolytic activity of V. alginolyticus on blood agar 
 
 Hemolysis 
  Sheep blood Human blood 
Isolate α Β α β 
1-1 (4) - - - - 
1-1 (4-a) - - - - 
1-1 (8) - - - - 
1-2 (3) - - - - 
1-2 (3-a) - - - - 
1-2 (4) - - - - 
1-2 (7) - - - - 
1-2 (7-a) - - - - 
1-3 (1) - - - - 
1-3 (1-a) - - - - 
1-3 (2) - - - - 
1-3 (2-a) - - - - 
1-3 (3) - - - - 
1-3 (4) - - - - 
1-3 (4-a) - - - - 
1-3 (4-b) - - - - 
1-3 (5) - - - - 
1-3 (6) - - - - 
1-3 (6-a) - - - - 
1-3 (7) - - - - 
1-3 (10) - - - - 
1-4 (1) - - - - 
1-4 (2) - - - - 
2-1 (2) - - - - 
2-1 (2-a) - - - - 
2-1 (5) - - - - 
2-1 (6) - - - - 
2-1 (6-a) - - - - 
2-1 (7) - - - - 
2-1 (7-a) - - - - 
2-1 (9) - - - - 
2-2 (2) - - - - 
2-2 (2-a) - - - - 
2-2 (3) - - - - 
2-2 (3-a) - - - - 
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2-2 (7) - - - - 
2-2 (9) - - - - 
2-3 (1) - - - - 
2-3 (5) - - - - 
2-3 (5-a) - - - - 
2-3 (6) - - - - 
2-3 (6-a) - - - - 
2-3 (9) - - - - 
2-3 (9-a) - - - - 
3-1 (1) - - - - 
3-1 (1-a) - - - - 
4-1 (2) - - - - 
4-2 (2) - - - - 
4-3 (1) - - - - 
4-3 (2) - - - - 
4-5 (1) - - - - 
4-5 (1-a) - - - - 
4-5 (2) - - - - 
7-5 (1-a) - - - - 
8-1 (1) - - - - 
8-1 (1-a) - - - - 
11-4 (1) - - - - 
B9-1  - - - - 
B9-2  - - - - 
B9-3  - - - - 
A2 - - - - 
A14 - - - - 
A19 - - - - 
A20 - - - - 
 
 
 
 
 
